TWI429461B - 製造薄膜及口部照護組成物之方法 - Google Patents
製造薄膜及口部照護組成物之方法 Download PDFInfo
- Publication number
- TWI429461B TWI429461B TW096125482A TW96125482A TWI429461B TW I429461 B TWI429461 B TW I429461B TW 096125482 A TW096125482 A TW 096125482A TW 96125482 A TW96125482 A TW 96125482A TW I429461 B TWI429461 B TW I429461B
- Authority
- TW
- Taiwan
- Prior art keywords
- film
- active ingredient
- medium
- agent
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 171
- 238000000034 method Methods 0.000 title claims description 41
- 239000004480 active ingredient Substances 0.000 claims description 183
- -1 perrhenate Chemical class 0.000 claims description 119
- 239000003795 chemical substances by application Substances 0.000 claims description 47
- 238000012546 transfer Methods 0.000 claims description 44
- 229920000642 polymer Polymers 0.000 claims description 42
- 239000004094 surface-active agent Substances 0.000 claims description 29
- 239000002904 solvent Substances 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 20
- 150000002978 peroxides Chemical class 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- 230000002087 whitening effect Effects 0.000 claims description 15
- 229920001577 copolymer Polymers 0.000 claims description 14
- 239000004014 plasticizer Substances 0.000 claims description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 229920003169 water-soluble polymer Polymers 0.000 claims description 12
- 239000000945 filler Substances 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 8
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 229920002125 Sokalan® Polymers 0.000 claims description 7
- 235000009508 confectionery Nutrition 0.000 claims description 7
- 239000000551 dentifrice Substances 0.000 claims description 7
- 235000003599 food sweetener Nutrition 0.000 claims description 7
- 239000003906 humectant Substances 0.000 claims description 7
- 239000011976 maleic acid Substances 0.000 claims description 7
- 229920000058 polyacrylate Polymers 0.000 claims description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- 239000003765 sweetening agent Substances 0.000 claims description 7
- 239000002562 thickening agent Substances 0.000 claims description 7
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 6
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 6
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 6
- 239000004034 viscosity adjusting agent Substances 0.000 claims description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 5
- 239000004584 polyacrylic acid Substances 0.000 claims description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 229920013820 alkyl cellulose Polymers 0.000 claims description 4
- 239000004599 antimicrobial Substances 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000001087 glyceryl triacetate Substances 0.000 claims description 4
- 235000013773 glyceryl triacetate Nutrition 0.000 claims description 4
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 239000003607 modifier Substances 0.000 claims description 4
- 125000005342 perphosphate group Chemical group 0.000 claims description 4
- 235000013772 propylene glycol Nutrition 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 235000010356 sorbitol Nutrition 0.000 claims description 4
- 229960002622 triacetin Drugs 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- 239000002269 analeptic agent Substances 0.000 claims description 3
- 230000002882 anti-plaque Effects 0.000 claims description 3
- 238000009792 diffusion process Methods 0.000 claims description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 3
- 150000004965 peroxy acids Chemical class 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 210000003296 saliva Anatomy 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- 208000006558 Dental Calculus Diseases 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000000181 anti-adherent effect Effects 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- 239000008377 tooth whitener Substances 0.000 claims description 2
- 241001674044 Blattodea Species 0.000 claims 1
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical class [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 claims 1
- 239000000043 antiallergic agent Substances 0.000 claims 1
- MMCOUVMKNAHQOY-UHFFFAOYSA-N carbonoperoxoic acid Chemical class OOC(O)=O MMCOUVMKNAHQOY-UHFFFAOYSA-N 0.000 claims 1
- 125000005670 ethenylalkyl group Chemical group 0.000 claims 1
- 229960005150 glycerol Drugs 0.000 claims 1
- 229960002920 sorbitol Drugs 0.000 claims 1
- 239000010408 film Substances 0.000 description 250
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 37
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Substances OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 29
- 239000004615 ingredient Substances 0.000 description 29
- 239000000047 product Substances 0.000 description 22
- 239000000463 material Substances 0.000 description 19
- 239000003086 colorant Substances 0.000 description 18
- 239000003921 oil Substances 0.000 description 16
- 239000012071 phase Substances 0.000 description 16
- 239000003599 detergent Substances 0.000 description 15
- 239000012634 fragment Substances 0.000 description 15
- 229960002163 hydrogen peroxide Drugs 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 210000000214 mouth Anatomy 0.000 description 14
- 150000003839 salts Chemical class 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 12
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 12
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 12
- 229920002472 Starch Polymers 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 239000000975 dye Substances 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 150000004665 fatty acids Chemical group 0.000 description 11
- 239000004698 Polyethylene Substances 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 229920000573 polyethylene Polymers 0.000 description 10
- 239000011148 porous material Substances 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 235000019698 starch Nutrition 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Natural products CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 9
- 239000011575 calcium Substances 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 9
- 229960005069 calcium Drugs 0.000 description 9
- 229920002678 cellulose Polymers 0.000 description 9
- 239000001913 cellulose Substances 0.000 description 9
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 235000013355 food flavoring agent Nutrition 0.000 description 8
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 125000000129 anionic group Chemical group 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 239000000969 carrier Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 229940091250 magnesium supplement Drugs 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 239000011591 potassium Substances 0.000 description 7
- 229960003975 potassium Drugs 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 229940083542 sodium Drugs 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 229920003176 water-insoluble polymer Polymers 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 239000011149 active material Substances 0.000 description 6
- 125000002091 cationic group Chemical group 0.000 description 6
- 238000005202 decontamination Methods 0.000 description 6
- 230000003588 decontaminative effect Effects 0.000 description 6
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 239000006072 paste Substances 0.000 description 6
- 239000000344 soap Substances 0.000 description 6
- 229940045872 sodium percarbonate Drugs 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000003981 vehicle Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 229920003091 Methocel™ Polymers 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229910052788 barium Inorganic materials 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 229910052744 lithium Inorganic materials 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 229920001983 poloxamer Polymers 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 5
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 4
- 229940035676 analgesics Drugs 0.000 description 4
- 239000000730 antalgic agent Substances 0.000 description 4
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 4
- 230000002272 anti-calculus Effects 0.000 description 4
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000007844 bleaching agent Substances 0.000 description 4
- 229940112822 chewing gum Drugs 0.000 description 4
- 235000015218 chewing gum Nutrition 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 229940041616 menthol Drugs 0.000 description 4
- 239000008375 oral care agent Substances 0.000 description 4
- 229960000502 poloxamer Drugs 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000011118 polyvinyl acetate Substances 0.000 description 4
- 229920002689 polyvinyl acetate Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 229960001922 sodium perborate Drugs 0.000 description 4
- 239000001488 sodium phosphate Substances 0.000 description 4
- 235000019832 sodium triphosphate Nutrition 0.000 description 4
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 4
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 4
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 3
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 229920000388 Polyphosphate Polymers 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 3
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 229920006243 acrylic copolymer Polymers 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000003213 antiperspirant Substances 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004061 bleaching Methods 0.000 description 3
- 229960003260 chlorhexidine Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000004927 clay Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 239000002979 fabric softener Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 229920005646 polycarboxylate Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000001205 polyphosphate Substances 0.000 description 3
- 235000011176 polyphosphates Nutrition 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000009877 rendering Methods 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 238000000807 solvent casting Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 235000010215 titanium dioxide Nutrition 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- NDDLLTAIKYHPOD-ISLYRVAYSA-N (2e)-6-chloro-2-(6-chloro-4-methyl-3-oxo-1-benzothiophen-2-ylidene)-4-methyl-1-benzothiophen-3-one Chemical compound S/1C2=CC(Cl)=CC(C)=C2C(=O)C\1=C1/SC(C=C(Cl)C=C2C)=C2C1=O NDDLLTAIKYHPOD-ISLYRVAYSA-N 0.000 description 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 2
- AQAINAJAHUPYEU-UHFFFAOYSA-N 2,3-dimethylfluoren-1-one Chemical compound C1=CC=C2C3=CC(C)=C(C)C(=O)C3=CC2=C1 AQAINAJAHUPYEU-UHFFFAOYSA-N 0.000 description 2
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 2
- PMNLUUOXGOOLSP-UHFFFAOYSA-N 2-mercaptopropanoic acid Chemical compound CC(S)C(O)=O PMNLUUOXGOOLSP-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 102000005927 Cysteine Proteases Human genes 0.000 description 2
- 108010005843 Cysteine Proteases Proteins 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 241000218378 Magnolia Species 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 240000007673 Origanum vulgare Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 241000220324 Pyrus Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- 229920001800 Shellac Polymers 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 240000006909 Tilia x europaea Species 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000008365 aqueous carrier Substances 0.000 description 2
- 229960003589 arginine hydrochloride Drugs 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 150000004283 biguanides Chemical class 0.000 description 2
- 150000004287 bisbiguanides Chemical class 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 238000000071 blow moulding Methods 0.000 description 2
- 235000012745 brilliant blue FCF Nutrition 0.000 description 2
- 239000004161 brilliant blue FCF Substances 0.000 description 2
- 239000004067 bulking agent Substances 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 235000015111 chews Nutrition 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940075484 d&c red no. 30 Drugs 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- WOAZEKPXTXCPFZ-UHFFFAOYSA-N dimethyl(phenyl)azanium;chloride Chemical compound Cl.CN(C)C1=CC=CC=C1 WOAZEKPXTXCPFZ-UHFFFAOYSA-N 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- 238000004851 dishwashing Methods 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- TVHALOSDPLTTSR-UHFFFAOYSA-H hexasodium;[oxido-[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O TVHALOSDPLTTSR-UHFFFAOYSA-H 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 description 2
- 235000012738 indigotine Nutrition 0.000 description 2
- 239000004179 indigotine Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 235000013980 iron oxide Nutrition 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 239000008204 material by function Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine group Chemical group P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229940068965 polysorbates Drugs 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- XXQBEVHPUKOQEO-UHFFFAOYSA-N potassium superoxide Chemical compound [K+].[K+].[O-][O-] XXQBEVHPUKOQEO-UHFFFAOYSA-N 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000004208 shellac Substances 0.000 description 2
- 229940113147 shellac Drugs 0.000 description 2
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 2
- 235000013874 shellac Nutrition 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 229960005076 sodium hypochlorite Drugs 0.000 description 2
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 229920003051 synthetic elastomer Polymers 0.000 description 2
- 239000005061 synthetic rubber Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 229940095064 tartrate Drugs 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 229910001432 tin ion Inorganic materials 0.000 description 2
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 2
- 235000019801 trisodium phosphate Nutrition 0.000 description 2
- 239000010455 vermiculite Substances 0.000 description 2
- 235000019354 vermiculite Nutrition 0.000 description 2
- 229910052902 vermiculite Inorganic materials 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- 239000002888 zwitterionic surfactant Substances 0.000 description 2
- CKUJRAYMVVJDMG-IYEMJOQQSA-L (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;tin(2+) Chemical compound [Sn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O CKUJRAYMVVJDMG-IYEMJOQQSA-L 0.000 description 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- SMOHSULBMKXDEN-RVDMUPIBSA-N (e)-1-n-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-2-nitro-1-n'-prop-2-ynylethene-1,1-diamine Chemical compound CN(C)CC1=CC=C(CSCCN\C(NCC#C)=C\[N+]([O-])=O)O1 SMOHSULBMKXDEN-RVDMUPIBSA-N 0.000 description 1
- JLPAMKUIIFHLBH-UHFFFAOYSA-N 1,2-dihydroxypropane-1-sulfonic acid Chemical compound CC(O)C(O)S(O)(=O)=O JLPAMKUIIFHLBH-UHFFFAOYSA-N 0.000 description 1
- OQBLGYCUQGDOOR-UHFFFAOYSA-L 1,3,2$l^{2}-dioxastannolane-4,5-dione Chemical compound O=C1O[Sn]OC1=O OQBLGYCUQGDOOR-UHFFFAOYSA-L 0.000 description 1
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- JCPGMXJLFWGRMZ-UHFFFAOYSA-N 1-(2-hydroxyphenyl)-3-phenylpropan-1-one Chemical compound OC1=CC=CC=C1C(=O)CCC1=CC=CC=C1 JCPGMXJLFWGRMZ-UHFFFAOYSA-N 0.000 description 1
- CLWAXFZCVYJLLM-UHFFFAOYSA-N 1-chlorohexadecane Chemical compound CCCCCCCCCCCCCCCCCl CLWAXFZCVYJLLM-UHFFFAOYSA-N 0.000 description 1
- KZYJXZMFIHHEML-UHFFFAOYSA-N 1-chlorohexadecane;pyridine Chemical compound C1=CC=NC=C1.CCCCCCCCCCCCCCCCCl KZYJXZMFIHHEML-UHFFFAOYSA-N 0.000 description 1
- QYXHFICHKVRPSH-UHFFFAOYSA-N 1-cyano-3-[4-[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]butyl]-2-methylguanidine Chemical compound N#CN=C(NC)NCCCCC1=CSC(NC(N)=N)=N1 QYXHFICHKVRPSH-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- JSWLXPQVSUEOJQ-UHFFFAOYSA-N 1-nonylperoxynonane Chemical compound CCCCCCCCCOOCCCCCCCCC JSWLXPQVSUEOJQ-UHFFFAOYSA-N 0.000 description 1
- CTMBNCSHOCVHMK-UHFFFAOYSA-M 1-pyridin-1-ium-1-ylhexadecan-1-one;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC(=O)[N+]1=CC=CC=C1 CTMBNCSHOCVHMK-UHFFFAOYSA-M 0.000 description 1
- YFVBASFBIJFBAI-UHFFFAOYSA-M 1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=CC=C1 YFVBASFBIJFBAI-UHFFFAOYSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical compound C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 description 1
- GCUYQYSERLQFFG-UHFFFAOYSA-N 2-(2-chloropropan-2-yl)octadecylbenzene Chemical compound CCCCCCCCCCCCCCCCC(C(C)(C)Cl)CC1=CC=CC=C1 GCUYQYSERLQFFG-UHFFFAOYSA-N 0.000 description 1
- JWNWCEAWZGLYTE-UHFFFAOYSA-N 2-(trimethylazaniumyl)butanoate Chemical compound CCC(C([O-])=O)[N+](C)(C)C JWNWCEAWZGLYTE-UHFFFAOYSA-N 0.000 description 1
- GEZAUFNYMZVOFV-UHFFFAOYSA-J 2-[(2-oxo-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetan-2-yl)oxy]-1,3,2$l^{5},4$l^{2}-dioxaphosphastannetane 2-oxide Chemical compound [Sn+2].[Sn+2].[O-]P([O-])(=O)OP([O-])([O-])=O GEZAUFNYMZVOFV-UHFFFAOYSA-J 0.000 description 1
- JDKAFLSRQPKFCQ-UHFFFAOYSA-N 2-[4-[2-[(4-amino-1-oxo-1,2,5-thiadiazol-3-yl)amino]ethylsulfanylmethyl]-1,3-thiazol-2-yl]guanidine Chemical compound S1C(N=C(N)N)=NC(CSCCNC=2C(=NS(=O)N=2)N)=C1 JDKAFLSRQPKFCQ-UHFFFAOYSA-N 0.000 description 1
- NPKLJZUIYWRNMV-UHFFFAOYSA-N 2-[decyl(dimethyl)azaniumyl]acetate Chemical compound CCCCCCCCCC[N+](C)(C)CC([O-])=O NPKLJZUIYWRNMV-UHFFFAOYSA-N 0.000 description 1
- HVYJSOSGTDINLW-UHFFFAOYSA-N 2-[dimethyl(octadecyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O HVYJSOSGTDINLW-UHFFFAOYSA-N 0.000 description 1
- KKMIHKCGXQMFEU-UHFFFAOYSA-N 2-[dimethyl(tetradecyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O KKMIHKCGXQMFEU-UHFFFAOYSA-N 0.000 description 1
- TYIOVYZMKITKRO-UHFFFAOYSA-N 2-[hexadecyl(dimethyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O TYIOVYZMKITKRO-UHFFFAOYSA-N 0.000 description 1
- BELZLSZHWJZDNM-UHFFFAOYSA-N 2-aminofluoren-1-one Chemical compound C1=CC=C2C3=CC=C(N)C(=O)C3=CC2=C1 BELZLSZHWJZDNM-UHFFFAOYSA-N 0.000 description 1
- ZIYRDJLAJYTELF-UHFFFAOYSA-N 2-bromo-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1Br ZIYRDJLAJYTELF-UHFFFAOYSA-N 0.000 description 1
- 229940106004 2-ethylhexyl benzoate Drugs 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- SJSIWDSXBLRJPE-UHFFFAOYSA-N 3,4-dichloro-2-phenoxyphenol Chemical compound OC1=CC=C(Cl)C(Cl)=C1OC1=CC=CC=C1 SJSIWDSXBLRJPE-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- JNKLWDBVVATNGF-UHFFFAOYSA-N 3-[(4-methylphenyl)methylidene]fluoren-1-one Chemical compound CC1=CC=C(C=C2CC(C3=CC4=CC=CC=C4C3=C2)=O)C=C1 JNKLWDBVVATNGF-UHFFFAOYSA-N 0.000 description 1
- KSBYXRUNSLGUNE-UHFFFAOYSA-N 3-amino-4-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]cyclobut-3-ene-1,2-dione Chemical compound O=C1C(=O)C(N)=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1 KSBYXRUNSLGUNE-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- USYAMXSCYLGBPT-UHFFFAOYSA-L 3-carboxy-3-hydroxypentanedioate;tin(2+) Chemical compound [Sn+2].OC(=O)CC(O)(C([O-])=O)CC([O-])=O USYAMXSCYLGBPT-UHFFFAOYSA-L 0.000 description 1
- MXRGSJAOLKBZLU-UHFFFAOYSA-N 3-ethenylazepan-2-one Chemical compound C=CC1CCCCNC1=O MXRGSJAOLKBZLU-UHFFFAOYSA-N 0.000 description 1
- IZTBLLPMEZOKSV-UHFFFAOYSA-N 3-n-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-oxo-1,2,5-thiadiazole-3,4-diamine Chemical compound O1C(CN(C)C)=CC=C1CSCCNC1=NS(=O)N=C1N IZTBLLPMEZOKSV-UHFFFAOYSA-N 0.000 description 1
- YVFNSFYHKSSVRN-UHFFFAOYSA-N 3-n-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]-1,2,5-thiadiazole-3,4-diamine;hydrochloride Chemical compound Cl.NC1=NSN=C1NCCCOC1=CC=CC(CN2CCCCC2)=C1 YVFNSFYHKSSVRN-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- ANAAMBRRWOGKGU-UHFFFAOYSA-M 4-ethyl-1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=C(CC)C=C1 ANAAMBRRWOGKGU-UHFFFAOYSA-M 0.000 description 1
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- ALCSGJCIESECFD-UHFFFAOYSA-N 5-[3-[[amino(2,2,2-trifluoroethylimino)methyl]amino]-1-pyrazolyl]pentanamide Chemical compound NC(=O)CCCCN1C=CC(NC(N)=NCC(F)(F)F)=N1 ALCSGJCIESECFD-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 229920001685 Amylomaize Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical class N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OQXDQIHJDIILGU-UHFFFAOYSA-N C1(=CC=CC=2C3=CC=CC=C3CC12)[N+](C)(C)CC(=O)[O-] Chemical compound C1(=CC=CC=2C3=CC=CC=C3CC12)[N+](C)(C)CC(=O)[O-] OQXDQIHJDIILGU-UHFFFAOYSA-N 0.000 description 1
- MNOILCPQIDMDNW-UHFFFAOYSA-N CC(CC)S(=O)(=O)O.C=CC Chemical compound CC(CC)S(=O)(=O)O.C=CC MNOILCPQIDMDNW-UHFFFAOYSA-N 0.000 description 1
- OXFLHHFVMAPXBZ-UHFFFAOYSA-N CC1(CCCCC1(C)OS(=O)(=O)O)C Chemical compound CC1(CCCCC1(C)OS(=O)(=O)O)C OXFLHHFVMAPXBZ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 235000019499 Citrus oil Nutrition 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 241001634499 Cola Species 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229930182827 D-tryptophan Natural products 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical class CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- GLWQRIMWMLJRIB-UHFFFAOYSA-N F.F.CCO Chemical compound F.F.CCO GLWQRIMWMLJRIB-UHFFFAOYSA-N 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- 241001065700 Ficus glabrata Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 102100031416 Gastric triacylglycerol lipase Human genes 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 108010061711 Gliadin Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- XKTMIJODWOEBKO-UHFFFAOYSA-M Guinee green B Chemical compound [Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC=CC=2)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 XKTMIJODWOEBKO-UHFFFAOYSA-M 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 240000004153 Hibiscus sabdariffa Species 0.000 description 1
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 description 1
- 229940122236 Histamine receptor antagonist Drugs 0.000 description 1
- 102000006492 Histatins Human genes 0.000 description 1
- 108010019494 Histatins Proteins 0.000 description 1
- 101000941284 Homo sapiens Gastric triacylglycerol lipase Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 229920003083 Kollidon® VA64 Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- KMZQAVXSMUKBPD-DJWKRKHSSA-N Lafutidine Chemical compound C=1C=COC=1C[S+]([O-])CC(=O)NC\C=C/COC(N=CC=1)=CC=1CN1CCCCC1 KMZQAVXSMUKBPD-DJWKRKHSSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229920003098 Methocel™ E5 LV Polymers 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 101100462438 Mus musculus Otulin gene Proteins 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- SRIJLARXVRHZKD-UHFFFAOYSA-N OP(O)=O.C=CC1=CC=CC=C1 Chemical compound OP(O)=O.C=CC1=CC=CC=C1 SRIJLARXVRHZKD-UHFFFAOYSA-N 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 235000010677 Origanum vulgare Nutrition 0.000 description 1
- 235000004383 Origanum vulgare subsp. vulgare Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000005291 Rumex acetosa Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical group C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- RSRJCYZEMGBMDE-UHFFFAOYSA-J [K+].[K+].[K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O.[O-]S(=O)(=O)OOS([O-])(=O)=O Chemical compound [K+].[K+].[K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O.[O-]S(=O)(=O)OOS([O-])(=O)=O RSRJCYZEMGBMDE-UHFFFAOYSA-J 0.000 description 1
- MQGOJIGNZXHKJO-UHFFFAOYSA-J [Li+].[Li+].[Li+].[Li+].[O-]S(=O)(=O)OOS([O-])(=O)=O.[O-]S(=O)(=O)OOS([O-])(=O)=O Chemical compound [Li+].[Li+].[Li+].[Li+].[O-]S(=O)(=O)OOS([O-])(=O)=O.[O-]S(=O)(=O)OOS([O-])(=O)=O MQGOJIGNZXHKJO-UHFFFAOYSA-J 0.000 description 1
- ZUBBEPRFYIQTHT-UHFFFAOYSA-N [Na].N1=C(C=CC2=CC=CC=C12)C1C(C2=CC=CC=C2C1)=O Chemical compound [Na].N1=C(C=CC2=CC=CC=C12)C1C(C2=CC=CC=C2C1)=O ZUBBEPRFYIQTHT-UHFFFAOYSA-N 0.000 description 1
- NBVZMBLJRHUOJR-UHFFFAOYSA-N [amino-[4-[6-[4-[amino(azaniumylidene)methyl]phenoxy]hexoxy]phenyl]methylidene]azanium;2-hydroxyethanesulfonate Chemical compound OCCS(O)(=O)=O.OCCS(O)(=O)=O.C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 NBVZMBLJRHUOJR-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229910052925 anhydrite Inorganic materials 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 229940098164 augmentin Drugs 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229910001422 barium ion Inorganic materials 0.000 description 1
- ZJRXSAYFZMGQFP-UHFFFAOYSA-N barium peroxide Chemical compound [Ba+2].[O-][O-] ZJRXSAYFZMGQFP-UHFFFAOYSA-N 0.000 description 1
- ULJKSEURFGAKRV-UHFFFAOYSA-J barium(2+) sulfonatooxy sulfate Chemical compound [Ba+2].[Ba+2].[O-]S(=O)(=O)OOS([O-])(=O)=O.[O-]S(=O)(=O)OOS([O-])(=O)=O ULJKSEURFGAKRV-UHFFFAOYSA-J 0.000 description 1
- ZCHPOKZMTJTNHI-UHFFFAOYSA-L barium(2+);sulfonatooxy sulfate Chemical compound [Ba+2].[O-]S(=O)(=O)OOS([O-])(=O)=O ZCHPOKZMTJTNHI-UHFFFAOYSA-L 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UADWUILHKRXHMM-ZDUSSCGKSA-N benzoflex 181 Natural products CCCC[C@H](CC)COC(=O)C1=CC=CC=C1 UADWUILHKRXHMM-ZDUSSCGKSA-N 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229940087373 calcium oxide Drugs 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-N calcium;phosphoric acid Chemical compound [Ca+2].OP(O)(O)=O.OP(O)(O)=O YYRMJZQKEFZXMX-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- SKOLWUPSYHWYAM-UHFFFAOYSA-N carbonodithioic O,S-acid Chemical class SC(S)=O SKOLWUPSYHWYAM-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 229940119201 cedar leaf oil Drugs 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 159000000006 cesium salts Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 239000010500 citrus oil Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- AZSFNUJOCKMOGB-UHFFFAOYSA-K cyclotriphosphate(3-) Chemical compound [O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 AZSFNUJOCKMOGB-UHFFFAOYSA-K 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- PNOXNTGLSKTMQO-UHFFFAOYSA-L diacetyloxytin Chemical compound CC(=O)O[Sn]OC(C)=O PNOXNTGLSKTMQO-UHFFFAOYSA-L 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- YRTMEEURRDTMST-UHFFFAOYSA-N diazetidine Chemical compound C1CNN1 YRTMEEURRDTMST-UHFFFAOYSA-N 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- QDOXWKRWXJOMAK-UHFFFAOYSA-N dichromium trioxide Chemical compound O=[Cr]O[Cr]=O QDOXWKRWXJOMAK-UHFFFAOYSA-N 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- BHDAXLOEFWJKTL-UHFFFAOYSA-L dipotassium;carboxylatooxy carbonate Chemical compound [K+].[K+].[O-]C(=O)OOC([O-])=O BHDAXLOEFWJKTL-UHFFFAOYSA-L 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010079553 euphauserase Proteins 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- 235000019240 fast green FCF Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000008394 flocculating agent Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical class O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 229940020947 fluorescein sodium Drugs 0.000 description 1
- 229940091249 fluoride supplement Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000007983 food acid Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 150000002241 furanones Chemical class 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical class COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229960001915 hexamidine Drugs 0.000 description 1
- OQLKNTOKMBVBKV-UHFFFAOYSA-N hexamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 OQLKNTOKMBVBKV-UHFFFAOYSA-N 0.000 description 1
- 229960001715 hexamidine isethionate Drugs 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 229960004867 hexetidine Drugs 0.000 description 1
- 229960003258 hexylresorcinol Drugs 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- UWNADWZGEHDQAB-UHFFFAOYSA-N i-Pr2C2H4i-Pr2 Natural products CC(C)CCC(C)C UWNADWZGEHDQAB-UHFFFAOYSA-N 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical class C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 239000002655 kraft paper Substances 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 229960003303 lafutidine Drugs 0.000 description 1
- 229940094506 lauryl betaine Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- HPGPEWYJWRWDTP-UHFFFAOYSA-N lithium peroxide Chemical compound [Li+].[Li+].[O-][O-] HPGPEWYJWRWDTP-UHFFFAOYSA-N 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 229960004995 magnesium peroxide Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- DSJNICGAALCLRF-UHFFFAOYSA-L magnesium;oxidooxy(oxo)borane Chemical compound [Mg+2].[O-]OB=O.[O-]OB=O DSJNICGAALCLRF-UHFFFAOYSA-L 0.000 description 1
- 150000002689 maleic acids Chemical class 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- BSDKWFAJZDUHKQ-UHFFFAOYSA-N methoxyethene Chemical compound COC=C.COC=C BSDKWFAJZDUHKQ-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical group COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CPQCBGMVDITBNW-UHFFFAOYSA-N n-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1,1-dioxothieno[3,4-d][1,2]thiazol-3-amine Chemical compound O1C(CN(C)C)=CC=C1CSCCNC1=NS(=O)(=O)C2=CSC=C12 CPQCBGMVDITBNW-UHFFFAOYSA-N 0.000 description 1
- HJZUEASXFDHGDQ-UHFFFAOYSA-N n-[3-[3-[(3-methylpiperidin-1-yl)methyl]phenoxy]propyl]-1-oxidopyridin-1-ium-3-carboxamide Chemical compound C1C(C)CCCN1CC1=CC=CC(OCCCNC(=O)C=2C=[N+]([O-])C=CC=2)=C1 HJZUEASXFDHGDQ-UHFFFAOYSA-N 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- GPLSFQUFEXQHCN-UHFFFAOYSA-N n-phenylmethoxymethanamine;hydrochloride Chemical compound Cl.CNOCC1=CC=CC=C1 GPLSFQUFEXQHCN-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
- 229960004872 nizatidine Drugs 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- CACRRXGTWZXOAU-UHFFFAOYSA-N octadecane-1-sulfonic acid Chemical compound CCCCCCCCCCCCCCCCCCS(O)(=O)=O CACRRXGTWZXOAU-UHFFFAOYSA-N 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 description 1
- RPQUGMLCZLGZTG-UHFFFAOYSA-N octyl cyanoacrylate Chemical compound CCCCCCCCOC(=O)C(=C)C#N RPQUGMLCZLGZTG-UHFFFAOYSA-N 0.000 description 1
- UZZYXUGECOQHPU-UHFFFAOYSA-N octyl hydrogen sulfate Chemical compound CCCCCCCCOS(O)(=O)=O UZZYXUGECOQHPU-UHFFFAOYSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 210000002379 periodontal ligament Anatomy 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 125000000864 peroxy group Chemical group O(O*)* 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical class O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229940044476 poloxamer 407 Drugs 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920000157 polyfructose Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- COALSIYJQHMCDX-UHFFFAOYSA-L propanedioate;tin(2+) Chemical compound [Sn+2].[O-]C(=O)CC([O-])=O COALSIYJQHMCDX-UHFFFAOYSA-L 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 239000001327 prunus amygdalus amara l. extract Substances 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000004172 quinoline yellow Substances 0.000 description 1
- 235000012752 quinoline yellow Nutrition 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 239000000985 reactive dye Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 102220047090 rs6152 Human genes 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 235000003513 sheep sorrel Nutrition 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- BCXJDMHGGXIZPY-UHFFFAOYSA-M sodium phosphono dihydrogen phosphate phosphono hydrogen phosphate Chemical compound [O-]P(O)(=O)OP(=O)(O)O.[Na+].OP(O)(=O)OP(=O)(O)O BCXJDMHGGXIZPY-UHFFFAOYSA-M 0.000 description 1
- ZIQRIAYNHAKDDU-UHFFFAOYSA-N sodium;hydroiodide Chemical compound [Na].I ZIQRIAYNHAKDDU-UHFFFAOYSA-N 0.000 description 1
- YKOLYTVUIVUUDY-UHFFFAOYSA-K sodium;zinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Na+].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YKOLYTVUIVUUDY-UHFFFAOYSA-K 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 235000012751 sunset yellow FCF Nutrition 0.000 description 1
- 239000004173 sunset yellow FCF Substances 0.000 description 1
- 239000002426 superphosphate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000979 synthetic dye Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000001789 thuja occidentalis l. leaf oil Substances 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- GTQFPPIXGLYKCZ-UHFFFAOYSA-L zinc chlorate Chemical compound [Zn+2].[O-]Cl(=O)=O.[O-]Cl(=O)=O GTQFPPIXGLYKCZ-UHFFFAOYSA-L 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 229940071566 zinc glycinate Drugs 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical compound [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0008—Detergent materials or soaps characterised by their shape or physical properties aqueous liquid non soap compositions
- C11D17/0013—Liquid compositions with insoluble particles in suspension
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Detergent Compositions (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- General Preparation And Processing Of Foods (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Description
本專利申請案主張於2006年7月14日提出申請之美國專利申請案序號11/457,610之優先權,其內容係以提及之方式併入本文中。
本發明關於一種製造具有活性成分之薄膜之方法。
包含官能性或活性材料之薄膜於多種之應用中係有用的,包括口部照護、個人照護、家庭照護及去污之產品。此種薄膜通常係儲存於產品之載體或媒液中。於使用時,薄膜通常係經由化學或物理之分裂而降解,藉此釋出活性或官能性材料進入周圍之環境中。以此種方式,薄膜提供高濃度之活性材料於接近目標表面之定域之釋出之機會。
生成此等材料之習用方法於製造之期間將官能性或活性材料組合入薄膜中。然後時常將薄膜切割成薄片或斷片,將其等引進及分散入產品載體中。然而,於儲存之期間,由於在薄膜中之活性材料之潛在之自薄膜移動進入載體中、及/或與於載體中之不相容成分之負面之相互作用,因此具有在薄膜中之該活性材料之不安定性之可能性。此外,將活性材料加入薄膜製造方法中之另外階段具有附隨之製造費用。
因此,製造用於多種消費性產品之包含此等活性材料之薄膜之可選擇及改良之方法係合意的。此外,開發於儲存之期間係安定之組成物,亦係合意的。
於多種具體實施例中,本發明係關於一種製造薄膜之方法,該方法包含將實質上不含活性成分之薄膜引進入包含活性成分之介質中。薄膜係致使活性成分可適合地轉移至其者。於某些具體實施例中,薄膜係多孔的。較佳地,轉移至少一部分之存在於介質中之活性成分至薄膜。
於其他具體實施例中,提供用於製造口部照護、個人照護、去污及/或家庭照護組成物之方法。方法包含將薄膜引進入包含活性成分之介質中。較佳地,薄膜實質上不含活性成分,但係致使活性成分可適合地轉移至其者。於某些具體實施例中,方法包含自介質轉移至少一部分之活性成分至薄膜,其中發生轉移直到薄膜包含有效數量之經轉移之活性成分為止,致使該薄膜係適合於作為至少一種之口部照護、個人照護、去污及/或家庭照護組成物之使用。此等組成物可係經由將包含經轉移之活性成分之薄膜引進入載體中而製備,其中包含經轉移之活性成分之薄膜於組成物之儲存之期間係安定的。
於再其他具體實施例中,一種製造口部照護組成物之方法包含將薄膜引進入包含口部活性成分之介質中。口部活性成分包含潔白劑。薄膜實質上不含活性成分,及係致使該活性成分可適合地轉移至其者。自介質轉移至少一部分之口部活性成分至薄膜。發生轉移直到薄膜包含有效數量之已轉移之活性成分為止,致使薄膜係適合於口部照護組成物中之使用。口部照護組成物係經由將包含經轉移之口部活性成分之薄膜引進入載體中而製備。此外,包含經轉移之活性成分之薄膜於口部照護組成物之儲存之期間係安定的。
遍及本揭示中,使用範圍作為用於敘述於範圍內每種及所有數值之以速記記錄之文字。可選擇於範圍內之任何值作為範圍之終點。此外,遍及本揭示中提及之所有參考資料係以提及之方式完整地明確地併入本文中。如於本文中使用,除非不同地表示,否則關於成分之濃度之所有提及係以重量為基礎。
於多種具體實施例中,本發明提供製造包含活性成分之薄膜之方法。特定言之,本發明之具體實施例係關於將活性成分引進入薄膜中之方法。
於多種類型之組成物中,包含活性成分之薄膜係有用的,特定言之於消費性產品中,諸如口部照護、個人照護、去污及/或家庭照護組成物。此等組成物通常包含載體,其中引進入及分布薄膜。習用地,活性成分係於薄膜之製造之期間(即,於溶劑澆鑄、擠製、吹氣模造、及其類似製造之期間)連同其他先質組合入薄膜中。然後,將包含活性成分之薄膜加入組成物之載體中。
然而,引進活性成分進入薄膜中之此種方法可係相當昂貴的。通常,其於製造之期間添加另外之處理階段及另外可能將無效率引進入處理中。此外,其可能限制用於薄膜之製造之處理條件,俾能保護活性成分免於經由因素諸如熱、壓力、過度物理力、苛性之溶劑、或固化劑而去活化或毀壞。當將活性成分引進入組成物之載體中時,具有薄膜於載體中之不安定性之另外可能性。例如,已有時觀察到,活性成分自薄膜擴散進入載體中,因此降低活性成分於薄膜中之定域之濃度。及降低組成物之功效。
對照地,於本發明之多種具體實施例中提供優越之方法。較佳之方法包含將薄膜引進入包含活性成分之介質中,其中薄膜實質上不含活性成分,及其中薄膜係致使可適合地轉移活性成分至其者。如於本文中使用,“實質上不含”意表活性成分不存在於薄膜達到其不是以有效之含量存在及/或不能被偵測出之程度。然後,轉移至少一部分之存在於介質中之活性成分至薄膜。
如於本文中使用,術語“轉移”意表自介質移動或輸送活性成分進入薄膜中。此術語涵蓋活性成分分子之被動及主動之移動進入薄膜中。被動之轉移通常不需要外部原動力(例如,機械力、化學及/或熱能)以達成活性成分之移動。被動之轉移通常涵蓋包括擴散之質量輸送現象,其中活性成分分子係物理地輸送通過濃度梯度以接近熱力學之平衡。此外,被動之轉移可包括電化學相互作用、吸收、吸附、及/或活性成分之燈撚形式擴散之(wicking)移動進入薄膜中,其中不需要外部原動力之施加以達成活性成分之充分之移動進入薄膜中。主動之輸送表示外部力量或原動力(諸如溫度、壓力、電及/或機械力)之施加,以達成活性成分自介質之移動進入薄膜中。例如,外部力量或原動力之施加可促進活性成分分子對抗電梯度或物理輸送障壁之移動。
於某些具體實施例中,提供一種製造口部照護、個人照護、去污及/或家庭照護組成物之方法。方法包含將薄膜引進入包含活性成分之介質中。薄膜實質上不含活性成分,及係致使可轉移活性成分至其者。於某些具體實施例中,薄膜係多孔的。轉移至少一部分之存在於介質中之活性成分至薄膜中。發生轉移直到薄膜包含有效數量之經轉移之活性成分為止,致使薄膜係適合於作為至少一種之口部照護、個人照護、去污及/或家庭照護組成物使用。組成物係經由將包含經轉移之活性成分之薄膜引進入載體中而製備,其中包含經轉移之活性成分之薄膜於組成物之儲存之期間係安定的。
活性成分之“有效”數量係促成其計畫之目的及/或用途及/或對於該目的及/或用途具有可偵檢之效果之數量。較佳地,有效數量係對於其施用包含薄膜之組成物之目標(例如,人類或較低等動物軀體、家務之表面及其類似物),足夠以具有合適之治療、清潔及/或預防疾病效果之數量。較佳地,與合理之危險/利益比相稱,活性成分不引發過度之負面副作用(諸如毒性、刺激、過敏之反應)。活性成分之特定之有效數量將隨著因素變動,諸如受治療之特殊情況或軀體、身體狀況、合併治療(倘若具有)之本質、使用之特定之活性成分、特定之劑量形式、使用之載體、及合適之給藥方案。
因此,活性成分選擇依賴使用組成物之用途(即彼等之計畫之目的)而定。因此,如於本文中使用,“活性成分”係於組成物中具有合適之效用之物質。於多種具體實施例中,此等效用可係去污、保護、治療、化妝、美感、裝飾、及感覺、或其等之組合。如上述,可使用本發明之組成物於多種之目標表面上,包括工業、家務、人類及動物軀體之表面,特定言之口內、皮膚、及角質之表面。目標表面之非限制之實例包括口內表面,諸如牙齒琺瑯質;皮膚表面,諸如皮膚;角質之組織表面,諸如指甲及頭髮;家務之表面,諸如五金器具、裝置物、纖維、織物、餐具、家用貨物、瓦、地板、陶磁、金屬、及其類似物。活性成分包括被選擇以分別地維持於載體中及經由薄膜而獨立地輸送及釋出者,及可包括被認為係載體成分之化合物及成分,反之亦然。
例如,可於口部照護組成物中供應包含活性物質之薄膜,其可係於潔齒劑(包括牙膏、牙凝膠、漱口水、牙粉、及預防疾病糊劑)、糖食(包括口香糖、粒狀物及咀嚼物)、薄膜、塗抹產品、職業之磨光調配物之形式或已為熟諳此項技藝者所知之任何其他形式。亦可使用薄膜於個人照護組成物中,諸如,例如,肥皂、沐浴膠、身體洗劑、去角質凝膠(exfoliating scrub)、洗髮精、乳液、遮陽劑、仿曬潤色之產品、止汗劑及除臭劑產品、指甲照護產品、及其類似物。同樣地,亦可使用薄膜於去污劑及/或家庭照護組成物中,包括,例如,粉末、糊劑、洗碗碟之液體及自動洗碗機清潔劑、織物清潔劑及軟化劑、及硬表面去污劑。
活性成分之下列之討論僅係例示的,及不應認為如限制根據本發明之方法可引進入薄膜中之活性成分之範圍,如用於被涵蓋之此等多種類型之組成物之已為熟諳此項技藝者所知之所有適合之活性成分。當然,雖然於彼等之活性中,每種之以上種類之活性成分之一般性質可不同,但是可具有某些共同之性質,及任何指定之物質可適合於兩種或更多之此等種類範圍內之多種目的及可適合於多種類型之組成物中之用途。
用於口部照護組成物之口部照護活性成分之非限制之實例,包括例如,牙齒潔白劑、抗微生物劑、防蛀劑、防牙垢劑、防齒斑劑、防黏著劑、脫過敏劑、消炎劑、惡臭控制劑、調味劑、著色劑、抗老化劑、唾液刺激劑、齒周膜之活性成分、調節劑、濕潤劑、潤滑劑、天然萃取物及香精油、營養品、酶、蛋白質、胺基酸、維生素、止痛劑、抗生素、及其混合物。,於頒予Nabi等人之美國專利第4,894,220號、皆頒予Gaffar等人之第5,288,480號及第5,776,435號、頒予Esposito等人之第5,681,548號、皆頒予Stringer等人之第5,912,274號及第5,723,500號、頒予Durga等人之第6,290,933號、及頒予Lawlor之第6,685,921號中、以及頒予Doyle等人之美國專利申請案公告第2003/0206874號中敘揭示於本文中有用者中之典型之活性成分。此外,口部照護活性成分之混合物,縱然於相同之分類之範圍內,亦係由本發明所涵蓋。
適合之口部活性成分之實例包括用於口內表面(諸如牙齒)之潔白劑。於多種具體實施例中,本發明之薄膜組成物於薄膜中包含一種或多種潔白劑。如以下進一步討論,“潔白劑”係對於漂白將其塗敷之硬組織口表面(即,琺瑯或其他牙齒表面)有效之物質。於本發明之一種具體實施例中,潔白劑包含過氧化物化合物。如於本文中提及,“過氧化物化合物”係包含二價之氧-氧基之氧化之化合物。
於某些具體實施例中,活性成分包含過氧化物化合物,其較佳地係以足夠以產生可偵測之漂白效果之任何數量存在於總口部照護組成物中。對於指定之過氧化物化合物,“氫-過氧化物-當量濃度”表示以相當於由純過氧化氫於相同條件下產生之過氧化氫離子之數量,產生過氧化氫離子或有機之過氧化物離子之過氧化物活性之化合物之數量。
較佳地,過氧化物化合物係以口部照護組成物之約1至約15%,視需要約1至約10%,視需要約3至約10%(以組成物之重量計)之口部照護組成物之氫-過氧化物-當量濃度之數量存在於口部照護組成物中。於某些較佳之具體實施例中,氫-過氧化物-當量濃度係於約2%至約8%之間;於某些具體實施例中,於約6%。
適合之過氧化物化合物可係輸送過氧化氫離子或有機之過氧化物離子之任何以過氧化物為基礎之潔白劑。此等過氧化物化合物包括過氧化物及氫過氧化物,諸如過氧化氫、鹼及鹼土金屬之過氧化物、有機之過氧基化合物、過氧酸、其醫藥上可接受之鹽及混合物。
於本發明之某些具體實施例中,潔白劑包含無機之產生過氧化氫之化合物諸如,例如,鹼金屬及鹼土金屬過硫酸鹽、二過硫酸鹽、過碳酸鹽、過磷酸鹽、過硼酸鹽、及過矽酸鹽諸如,例如,過硫酸鈉、二過硫酸鈉、過碳酸鈉、過磷酸鈉、過硼酸鈉、過矽酸鈉、過硫酸鉀、二過硫酸鉀、過碳酸鉀、過磷酸鉀、過硼酸鉀、過矽酸鉀、二過硫酸鋰、過碳酸鋰、過磷酸鋰、過硼酸鋰、過矽酸鋰、過硫酸鈣、二過硫酸鈣、過碳酸鈣、過磷酸鈣、過硼酸鈣、過矽酸鈣、過硫酸鋇、二過硫酸鋇、過碳酸鋇、過磷酸鋇、過硼酸鋇、過矽酸鋇、過硫酸鎂、二過硫酸鎂、過碳酸鎂、過磷酸鎂、過硼酸鎂、及過矽酸鎂鹽以及過氧化鈉、過氧化鉀、過氧化鋰、過氧化鈣、過氧化鋇及過氧化鎂,及以上之任何之組合。
於某些具體實施例中,潔白劑包含有機之過氧基化合物,其包括過氧化碳甲醯胺(亦以氫過氧化脲而為吾人所知)、氫過氧化甘油基、氫過氧化烷基、過氧化二烷基、烷基過氧酸、過氧酸酯、過氧化二醯基、過氧化苯甲醯基、及單過氧基酞酸酯、及其混合物。過氧酸及彼等之鹽包括有機之過氧酸諸如烷基過氧酸、及單過氧基酞酸酯及其混合物,以及無機之過氧酸鹽諸如鹼及鹼土金屬諸如鋰、鉀、鈉、鎂、鈣及鋇之過硫酸鹽、二過硫酸鹽、過碳酸鹽、過磷酸鹽、過硼酸鹽及過矽酸鹽、及其混合物。於多種具體實施例中,過氧化物化合物包含過氧化氫、過氧化脲、過碳酸鈉及其混合物。
於本發明之口部照護組成物中作為活性成分潔白劑特別有用之釋出過氧化物之化合物包括含過氧化物之化合物諸如過氧化脲、過碳酸鈉、過硼酸鈉及聚乙烯基吡咯啶酮-H2
O2
複合物(於後文中稱為〝PVP-H2
O2
〞)。PVP或聚乙烯基吡咯啶酮亦係以聚-N-乙烯基-聚-2-吡咯啶酮而已為吾人所知。PVP-H2
O2
之線型及交聯之複合物皆係於此項技藝中已知的,及係於皆頒予Shiraeff之美國專利第3,376,110號及第3,480,557號、及頒予Merianos等人之第5,122,370號中揭示。於無水之環境中,PVP-H2
O2
係安定的。於曝露於很水性之環境(諸如於口腔中)之後,PVP-H2
O2
分解成為個別之物種(PVP聚合物及H2
O2
)。於一種具體實施例中,PVP-H2
O2
複合物係約80%之聚乙烯基吡咯啶酮及20%之H2
O2
。PVP於PVP-H2
O2
複合物中之濃度不受潛在之PVP濃度影響,其中使用PVP作為用於形成薄膜之聚合物。
於多種具體實施例中,潔白劑包含過氧化物化合物諸如過氧化氫、過氧化脲、過碳酸鈉或其混合物。視選擇之潔白劑之氫-過氧化物-當量濃度而定,潔白劑較佳地構成約0.1至約50%,更佳地約0.1至約5%,最佳地約0.1至約2%之總口部照護組成物。於薄膜中,潔白劑較佳地構成約0.01至約50%,最佳地約0.1至約5%之薄膜。
於多種具體實施例中,活性成分係包含非離子化合物之口部活性成分。例如,非離子抗細菌劑包括酚系及/或雙酚系化合物,諸如,經鹵化之二苯基醚,其包括二氯苯氧氯酚(triclosan)(2,4,4’-三氯-2’-羥基-二苯基醚)、三氯二苯脲(3,4,4-三氯羰基苯胺)、2-苯氧基乙醇、苯甲酸酯類、羰基苯胺類、酚類、瑞香草酚、丁香酚、己基間苯二酚及2,2-亞甲基雙(4-氯-6-溴酚)。此等抗細菌劑可係以各種數量存在,諸如總口部照護組成物之約0.001至約5%重量比。
口部照護劑亦可視需要包含陽離子口部照護活性成分。對於口部照護組成物中之使用,適合之陽離子活性成分包括,例如:(i)四級銨化合物,諸如其中一個或兩個之於四級氮上之取代基具有8至20個(較佳地10至18個)碳原子及較佳地係烷基(其可視需要經由醯胺、酯、氧、硫、或雜環而間斷),而剩餘之取代基具有較低數目之碳原子(例如1至7個)及較佳地係烷基(例如甲基或乙基)、或苄基者。此等化合物之實例包括氯化苯基二甲烴銨、氯化十二基三甲銨、氯化苄基二甲基十八銨、溴化十六基三甲銨、氯化苄乙氧銨(氯化二異丁基(苯氧基乙氧基)乙基二甲基芳銨)、及氯化甲基苄乙氧銨;(ii)吡啶鎓及異喹啉鎓化合物,包括氯化十六基吡啶鎓、溴化烷基異喹啉鎓、氯化十四基吡啶鎓、及氯化N-十四基-4-乙基吡啶鎓;(iii)嘧啶衍生物諸如雙辛氫啶(hexetidine)(5-胺基-1,3-雙(2-乙基己基)-5-甲基-六氫嘧啶);(iv)脒衍生物諸如去氧苯比妥2-羥乙磺酸酯(hexamidine isethionate)(4,4’-二脒基-α,ω-二苯氧基-己烷2-羥乙磺酸酯);(v)雙吡啶衍生物諸如癸雙辛胺啶二氫氯酸鹽(octenidine hydrochloride)(N,N’[1,10-癸烷二基二-1(4H)-亞吡啶-4-基]-雙(1-辛胺)二氫氯酸鹽);(vi)胍,例如,單-縮二胍諸如對氯苄基-縮二胍及N’(4-氯苄基)-N”-(2,4-二氯苄基)縮二胍、聚(縮二胍)諸如聚六亞甲基縮二胍氫氯酸鹽、及通式(1)之雙-縮二胍:
(其中A及A1
每種代表(i)以(C1-4
)烷基、(C1-4
)烷氧基、硝基、或鹵素視需要取代之苯基,(ii)(C1-12
)烷基,或(iii)(C4-12
)非環之基;X及X1
每種代表(C1-3
)伸烷基;R及R1
每種代表氫、(C1-12
)烷基、或芳基(C1-6
)烷基;Z及Z1每種係0或1;n係2至12之整數;及聚亞甲基鏈(CH2
)n
可係視需要經由氧或硫或芳族(例如,苯基或萘基)核而間斷)、及其之口部可接受之酸加成鹽;此等雙-縮二胍之實例包括洗必泰(chlorhexidine)及雙胍啶(alexidine)。通式(1)之雙-縮二胍之適合之酸加成鹽包括二乙酸鹽、二氫氯酸鹽及二葡萄糖酸鹽。洗必泰之適合之酸加成鹽包括二葡萄糖酸鹽、二甲酸鹽、二乙酸鹽、二丙酸鹽、二氫氯酸鹽、二氫碘酸鹽、二乳酸鹽、二硝酸鹽、硫酸鹽、及酒石酸鹽。雙胍啶之適合之酸加成鹽包括二氫氟酸鹽及二氫氯酸鹽;及其他選用之陽離子化合物之口部照護劑包括Nα
-醯基胺基酸烷基酯及通常由以下之式(2)代表之鹽:
其中R1
係1至8個碳原子(較佳地1至3個碳原子,及最佳地3個碳原子)之烷基鏈;R2
係6至30個碳原子(較佳地10至12個碳原子)之烷基鏈、及其混合物;及X係陰離子。於多種具體實施例中,R2
CO基團包含天然之脂肪酸殘基諸如由椰子油脂肪酸、牛脂脂肪酸殘基組成之群中選出之天然之脂肪酸,或單脂肪酸殘基諸如由月桂醯基(C12
)、肉豆蔻醯基(C14
)、硬脂醯基(C18
)脂肪酸殘基、及其混合物組成之群中選出者。於某些具體實施例中,R2
CO基團包含月桂醯基脂肪酸殘基。
X可係提供於水中之合理溶解度(較佳地,於1升水中至少約1克)之任何之相對陰離子。X之實例包括生成以上認明之式之酯鹽、無機酸鹽(諸如包含鹵素原子者(例如,氯化物或溴化物)或二氫磷酸鹽)、或有機酸鹽(諸如乙酸鹽、酒石酸鹽、檸檬酸鹽、或吡咯啶酮-羧酸鹽(PCA))之相對陰離子。氯化物鹽係較佳的。
對於本發明口部照護組成物有用之其中於式中n等於3之以上認明之式之酯之實例包括Nα
-椰子醯基-L-精胺基酸甲酯、Nα
-椰子醯基-L-精胺酸乙酯、Nα
-椰子醯基-L-精胺酸丙酯、Nα
-硬脂醯基-L-精胺酸甲酯、Nα
-硬脂醯基-L-精胺酸乙酯鹽,諸如氫氯酸鹽。於一種具體實施例中,陽離子口部照護劑包含月桂醯基精胺酸乙酯(ELAH)之氫氯酸鹽。
於某些具體實施例中,較佳之陽離子活性成分係由氯化苯基二甲烴銨、癸雙辛胺啶、雙辛氫啶、去氧苯比妥(hexamidine)、氯化十六基吡啶鎓、洗必泰、雙胍啶、Nα
-醯基胺基酸烷基酯鹽、及其混合物組成之群中選出。於某些具體實施例中,陽離子口部照護活性成分包含氯化十六基吡啶鎓(CPC)。於某些具體實施例中,口部照護活性成分包含Nα
-醯基胺基酸烷基酯鹽,諸如月桂醯基精胺酸乙酯氫氯酸鹽(ELAH)。
於某些具體實施例中,口部照護活性成分係抗連結劑。雖然不限制於本發明,但是通常咸信,作為抗連結劑之口部照護活性成分與口內表面相互作用致使細菌及生物膜成分不能黏著於其上,或者經由與細菌本身相互作用、或許經由與通常將協助與於口腔表面之受納體或其他基團之鍵聯之於細菌之表面上之黏連素、配位子、或其他基團相互作用以使其不能連結於口內表面。雖然不限制於本發明,但是咸信於某些具體實施例中上述之Nα
-醯基胺基酸烷基酯鹽(諸如月桂醯基精胺酸乙酯氫氯酸鹽(ELAH))如抗連結之活性成分發生作用。
於某些具體實施例中,口部活性成分包含一種口部照護活性成分,該成分係生物膜分解劑。“生物膜分解劑”通常係預防於口內表面上生物膜(或表層)之形成及/或攻擊已於口內表面上生成之生物膜(或表層)之化合物,及包括能水解蛋白質、澱粉及脂質之酶,其形成生物膜基質之一部分。於某些具體實施例中,此種活性成分係酶,包括,例如,蛋白質酶,諸如半胱胺酸蛋白質酶或絲胺酸蛋白質酶。最佳之酶包括:香瓜素(例如,自番木瓜之綠色果實及葉子之乳膠分離出)、無化果蛋白質酶(例如,自熱帶無化果樹Ficus glabrata
之乳膠分離出)、krillase(例如,自南極磷蝦分離出)、其他之半胱胺酸及絲胺酸蛋白質酶、葡萄糖糖化酶、葡聚糖酶、變構水解酶(mutanase)、溶菌酶、植物脂酶、胃脂酶、胰脂酶、鞣酸脂酶、鳳梨酶、胰凝乳蛋白酶、蛋白質分解酶、amalysecs、乳鐵蛋白、牙齦蛋白酶、葡萄糖氧化酶、彈性硬蛋白酶及/或木纖維質酶、果膠酶、及其混合物。用於口腔之其他有用之生物膜分解劑包括合成之富組蛋白(histatin)、呋喃酮、呋喃酮之衍生物、及任何之以上之混合物。
除了以上記載者之外,本發明之口部照護組成物可視需要包含其他抗齒斑/齒斑分解劑,包括但不受限於:銅、鎂及鍶離子來源,通常以鹽形式供應;二甲矽酮烷共聚醇諸如鯨蠟基二甲矽酮烷共聚醇;尿素;乳酸鈣;甘油磷酸鈣;聚丙烯酸鍶;及其混合物。
於某些具體實施例中,口部照護劑包含一種屬於消炎劑之口部照護活性化合物。有用之消炎之化合物包括類黃素母酮、黃烷、白菊內酯類,諸如倍半萜烯內酯白菊內酯、男烯二醇(AED)及去氫異雄甾酮(DHEA)。其他有用之消炎劑包括非類固醇之消炎藥物(NSAIDs),諸如消炎痛(indomethicin)、氟聯苯丙酸(flurbiprofen)、酮基布洛芬(ketoprofen)、異丁苯丙酸(ibuprofen)、甲氧萘丙酸(naproxen)、甲氯滅酸、及其混合物。對於口部照護活性劑有用之其他適合消炎劑包括如於2005年10月24提出申請之頒予Worrell等人之美國專利申請案序號11/256,788中討論之薄荷科芬芳植物萃取物(例如,萃取自Origanum Vulgare
(通常如“薄荷科芬芳植物”、“野生薄荷科芬芳植物”或“野生馬鬱蘭”為吾人所知))、或如於2005年11月23提出申請之頒予Gaffar等人之美國專利申請案序號11/285,809中敘述之木蘭萃取物,其係自於木蘭料中之植物諸如木蘭屬厚樸衍生。
一種較佳之口部照護活性成分包含至少一種類黃素母酮與至少一種黃烷之組合,諸如UNIVESTIN,其係由Unigen Pharmaceuticals,Inc.(Superior,CO,United States of America)製造及銷售。於頒予Jia之美國專利申請案公告第2003/0216481中可找到UNIVESTIN之完整說明。
作為口部活性成分有用之抗氧化劑之實例包括丁基化之羥苯基甲基醚(BHA)、丁基化之羥基甲苯(BHT)、維生素A、類胡蘿蔔素、生育酚(維生素E)、類黃素母酮、多酚、抗壞血酸(維生素C)、草本之抗氧化劑、葉綠素、褪黑激素、氯化物、鈣、氧化鈣、氯化鈣、泛醌二鈉(輔酶Q10
)、五倍子酸乙基己酯、過氧化氫、碘、番茄紅素、抗壞血酸鎂、亞硫酸鉀、亞硫酸氫鈉、硫代乳酸、及其混合物。於某些具體實施例中,口部照護組成物包含一種屬於抗生素之口部照護活性成分,諸如安滅菌(augmentin)、羥氨苄青黴素(amoxicillin)、四環素(tetracyaline)、去氧土黴素(doxycycline)、二甲胺四環素(minocycline)、甲硝噠唑(metronidazole)、新黴素(neomycin)、卡那黴素(kanamycin)及氯潔黴素(clindamycin);及其混合物。
其他有用之口部活性成分包括氟離子來源,較佳地以足夠供應約25 ppm至約5,000 ppm之氟離子之數量存在,諸如氟化鈉、氟化鉀、氟矽酸鈉、氟矽酸銨、單氟磷酸鈉(MFP)、及氟化胺、包括奧拉氟(olaflur)(N’-十八基三亞甲二胺-N,N,N’-參(2-乙醇)-二氫氟酸鹽)。適合之二價錫離子來源包括但不受限於:氟化亞錫、其他之二價錫鹵化物諸如氯化亞錫二水合物、焦磷酸亞錫、有機之羧酸亞錫鹽諸如甲酸亞錫、乙酸亞錫、葡萄糖酸亞錫、乳酸亞錫、酒石酸亞錫、草酸亞錫、丙二酸亞錫及檸檬酸亞錫、乙烯果綠定亞錫及其類似物。一種或多種二價錫離子來源係以約0.01%至約10%之總數量選用地及說明地存在。鋅離子來源,諸如乙酸鋅、氯酸鋅、檸檬酸鋅、葡萄糖酸鋅、甘胺酸鋅、氧化鋅、硫酸鋅、檸檬酸鋅鈉及其類似物係以約0.05%至約3%之總數量說明地存在。
某些類型之有用之抗結石之活性成分係線型以分子方式脫水之聚磷酸鹽。聚磷酸鹽通常係以彼等之完全地或部分地中和之水溶性鹼金屬鹽(例如,鉀、鈉或銨鹽、及其任何混合物)之形式使用。因此,作為抗結石劑有用之線型以分子方式脫水之聚磷酸鹽化合物包括,例如,三聚磷酸鈉、六偏磷酸焦磷酸鈉、二鹼金屬或四鹼金屬焦磷酸鹽諸如Na4
P2
O7
、K4
P2
O7
、Na2
K2
P2
O7
、Na2
H2
P2
O7
及K2
H2
P2
O7
、及環狀之磷酸鹽諸如三聚磷酸鈉三偏磷酸鈉、或其混合物。於多種具體實施例中,此種抗齒垢活性成分以約0.001%至約10%,更佳地約1%至約5%之濃度存在於本發明之總口部照護組成物中。
對於某些口部照護活性成分,合成之陰離子線型聚羧酸鹽亦係以有效之增進劑而已為吾人所知,包括於口部照護組成物中之抗細菌劑、防齒垢劑或其他活性劑。此外,亦可使用此等化合物以形成薄膜,如於以下敘述。此等陰離子聚羧酸鹽通常係以彼等之自由酸,或較佳地部分地中和或更佳地完全地中和之水溶性鹼金屬(例如,鉀及較佳地鈉)或銨鹽之形式使用。較佳之共聚物係具有約30,000至約5,000,000之分子量(M.W.)之順丁烯二酐或酸與另一種可聚合之乙烯系不飽和單體(較佳地甲基乙烯基醚(甲氧基乙烯))之1:4至4:1共聚物。一種較佳之共聚物係甲基乙烯基醚/順丁烯二酐。有用之共聚物之實例係於商品名稱GANTREZ下自ISP公司可獲得者,例如,AN 139(分子量1,100,000)、AN 119(分子量200,000)、S-97醫藥級(分子量1,500,000)、AN 169(分子量2,000,000)、及AN 179(分子量2,400,000);其中較佳之共聚物係S-97醫藥級(分子量1,500,000)。於其中於口部照護組成物中包含合成之陰離子聚羧酸酯之多種具體實施例中,其較佳係以約0.001%至約5%重量存在。
可存在唾液刺激劑,其包括食物酸諸如檸檬酸、乳酸、順丁烯二酸、丁二酸、抗壞血酸、己二酸、反丁烯二酸及酒石酸、及其混合物。H2
組織胺受體拮抗劑係其他有用之活性成分。於本文中有用之H2
拮抗劑包括甲腈咪胍、依汀替丁、呋喃硝胺、ICIA-5165、硫替丁、ORF-17578、魯匹替丁、多奈替丁、法莫替丁、羅莎替丁、哌芳替丁、蘭替丁、BL-6548、BMY-25271、唑替丁、尼扎替丁、咪芬替丁、BMY-52368、SKF-94482、BL-6341A、ICI-162846、雷索替丁、Wy-45727、SR-58042、BMY-25405、拉夫替丁、DA-4634、比芬替丁、舒福替丁、乙溴替丁、HE-30-256、D-16637、FRG-8813、FRG-8701、英普咪定、L-643728、HB-408.4、及其混合物。於本文中有用之脫敏感劑包括檸檬酸鉀、氯化鉀、酒石酸鉀、碳酸氫鉀、草酸鉀、硝酸鉀、鍶鹽、及其混合物。或者或另外地,可使用一種或多種局部或系統之止痛劑諸如阿斯匹林、可待因、對乙醯氨基酚、柳酸鈉或三乙醇胺柳酸鹽。
適合之營養劑包括維生素、礦物質、胺基酸、及其混合物。較佳之維生素包括維生素C及D、噻胺、核糖黃素、泛酸鈣、菸鹼酸、葉酸、菸鹼醯胺、吡哆醇、氰鈷銨素、對胺基苯甲酸、生物類黃酮、及其混合物。營養補充品包括胺基酸(諸如L-色胺酸、L-離胺酸、甲硫胺酸、蘇胺酸、左旋卡尼丁及L-肉鹼)、脂肪增多劑(諸如膽鹼、肌醇、甜菜鹼、及亞麻油酸)、魚油(包括其成分諸如ω-3(N-3)多不飽和之脂肪酸、二十碳五烯酸及二十二碳六烯酸)、及其混合物。
個人照護活性成分之非限制之實例包括表面活性劑、皮膚、頭髮、及指甲調節劑(例如,矽酮油、陽離子矽酮類、矽酮膠、高折射之矽酮、及矽酮樹脂及有機之調節油諸如烴油、聚烯烴、及脂肪酸酯)、皮膚及頭皮sensate、收斂劑、皮膚及頭皮緩和劑、皮膚癒合劑、潤濕劑、潤滑劑、皮膚潔白劑、抗微生物劑、消炎劑、惡臭控制劑、抗老化劑、抗粉刺劑、抗牛皮癬劑、抗頭皮屑劑、皮膚脂質流化劑、保濕劑、除臭之活性劑、止汗之活性劑、天然萃取物及香精油、營養品、閉合劑、酶、蛋白質、胺基酸、維生素、止痛劑、遮陽劑及紫外線吸收劑(例如,對甲氧基桂皮酸2-乙基己酯、N,N-二甲基-對胺基苯甲酸2-乙基己酯、對胺基苯甲酸、2-苯基苯并咪唑-5-磺酸、氰雙苯丙烯酸辛酯、氧苯酮、柳酸三甲環己酯(homomenthyl salicylate)、柳酸辛酯、4,4’-甲氧基第三丁基二苯甲醯基甲烷、4-異丙基二苯甲醯基甲烷、3-亞苄基莰酮、3-(4-甲基亞苄基)莰酮、二氧化鈦、氧化鋅、矽石、鐵氧化物)、抗氧化劑、抗生素、去角質霜、鉗合劑、著色劑(包括適合之著色劑諸如包括“直接作用染料”之非氧化之染料、金屬染料、金屬鉗合染料、纖維反應性染料及其他合成及天然之染料)、渾濁劑、仿曬潤色劑、除生物劑、止痛劑(外用的)。多種之此等活性成分係相同於以上於口部照護之內容中敘述者。涵蓋已為熟諳此項技藝者所知之其他成分。
於頭髮潤絲精及洗髮精中已使用陽離子界面活性劑(諸如四級銨鹽)作為調節劑,如已使用多種矽酮及其他不溶於水之調節劑,包括蠟、油脂及油。纖維調節劑之非限制之實例包括有機矽化合物,例如,非揮發性之矽酮(尤其胺基矽酮)、聚乙烯、石蠟、石蠟脂、微晶蠟、脂肪酸及三甘油酯(例如’C18-36
(混合)脂肪酸、硬脂酸十八酯)、及四級銨及胺鹽(其等亦充當界面活性劑)。於頒予Patel等人之美國專利第5,213,716號、頒予McAtee等人之第6,955,817號、頒予Kolodzik等人之第6,835,373號、及頒予Lintner之第6,974,799號中敘述典型之個人照護組成物及活性成分。
液體去污劑組成物包含活性成分諸如清潔之表面活性劑,其包括陰離子、陽離子、非離子及兩性肥皂界面活性劑、清潔劑增滌劑(諸如硫酸鹽(例如,硫酸鈉)、磷酸鹽(例如,磷酸三鈉、磷酸二鈉)、複合之磷酸鹽(例如,焦磷酸四鈉、三聚磷酸鈉、四磷酸鈉、六偏磷酸鈉)、矽酸鹽(例如,矽酸鈉、膠態矽酸鹽)、碳酸鹽(例如,碳酸鈉、碳酸氫鈉))、聚合之輔增滌劑、漂白之化合物(例如,次氯酸鈉、過硼酸鈉、過碳酸鈉)、活化劑、pH緩衝劑、酶、調節劑、稀釋劑、鉗合劑、酶、防再沈積聚合物、去污聚合物、聚合之分散污垢及/或懸浮污垢劑、染料轉移抑制劑、織物完整劑(fabric-integrity agents)、抑泡劑、織物柔軟劑、絮凝劑、香料、潔白劑、及其等之組合。於家務照護組成物中有用之活性成分包括,例如,清潔劑表面活性成分、清潔劑增滌劑、調節劑、天然之萃取物及香精油、酶、蛋白質、胺基酸、去污劑、潔白劑、抗微生物劑、臭味控制劑、及織物柔軟劑。於頒予Hokkirigawa等人之美國專利第6,670,318號、頒予Thomas等人之第5,294,364號、頒予Denis等人之第4,869,842號、頒予Lancz之第3,965,026號、頒予Drapier之美國專利公告第2003/0082131號、及頒予Meli等人之第2005/0272628號及PCT公告號碼世界智慧財產權組織專利97/11151中敘述典型之去污劑及家庭照護產品。
對於本發明有用之薄膜可係剛性或撓性的,包含任何之多種材料,包括形成薄膜之材料、黏土、蠟、及其混合物。於某些具體實施例中,薄膜包含至少一種形成薄膜之材料,較佳地包含聚合物。有用之聚合物包括親水性及疏水性聚合物。於某些具體實施例中,聚合物係可溶於溶劑中,諸如水。於使用之期間,於曝露於水及物理力之施加(諸如於刷牙或以刷子或墊磨擦之期間)之期間溶解之水溶性聚合物係良好的。於某些具體實施例中,聚合物不溶於水中但於水中經由可分散而可分裂的,即,由於機械或剪切力之施加之結果,聚合物分裂成為小碎體。於某些具體實施例中,聚合物不可溶的但係可潤脹的。於使用之期間聚合物不完全分裂之情況中,但其可係排斥水之聚合物或於水中穩定之親水性聚合物諸如某些類型之纖維素,例如,紙。於頒予Schiraldi等人之美國專利第4,713,243號、皆頒予Xu之第6,419,903號、第6,419,906號、第6,514,483號、及頒予Boyd等人之第6,669,929號;皆頒予Boyd等人之美國專利公告第2004/0126332號、第2004/0136924號、及第2004/0042976號、及頒予Moro等人之第2004/0062724號中敘述有用之聚合物之實例。
較佳地,選擇聚合物及將其分配於薄膜中以提供下列之至少一種:(1)包含活性成分於載體中之薄膜之合適之安定性、(2)於組成物之使用之期間薄膜之分解之合適之速率、或(3)於組成物之使用之期間活性成分之曝露之合適之速率。
於較佳具體實施例中,薄膜係水溶性的,其包含,例如,水溶性聚合物、可分散於水中之聚合物、或具有選用之水溶性填充劑之不溶於水之聚合物。可選擇不溶於水之聚合物、水溶性聚合物或選用之水溶性填充劑之相對數量,以釋出與如何強力地或如何長久地使用組成物(例如,於水性組成物之使用之期間經由刷、磨擦、或其他機械作用)成比例之數量之活性成分。
請注意,本發明之多種具體實施例係關於以複數之碎體、帶、片板、及其類似物供應之薄膜;包含活性成分之薄膜作為用於多種構件之包膠材料亦可係適合的。根據於本揭示中記載之原理,包膠薄膜可係相等地傾向於經歷活性成分自介質之轉移。
於某些具體實施例中,聚合物係水溶性聚合物。一種實例係纖維素醚聚合物,諸如羥烷基烷基纖維素,包括自Midland,MI,United States of America之Dow Chemical Company以METHOCEL產品市售之羥丙基甲基纖維素(HPMC)(包括,例如,METHOCELE5、METHOCELE5 LV、METHOCELE50、METHOCELE15、及METHOCELK100)、羥丙基纖維素(HPC)、羥乙基纖維素(HEC)、甲基纖維素(MC)、羧甲基纖維素(CMC)、及其混合物。其他有用之聚合物包括聚乙烯基吡咯啶酮(PVP)(其可具有約100,000或更多及至多約1.5百萬之重量平均分子量)、乙酸乙烯酯、聚乙烯基吡咯啶酮-乙酸乙烯酯共聚物諸如KOLLIDONVA64(自BASF可獲得,60:40重量比之乙烯基吡咯啶酮)及PLASDONES630 PVP(自International Specialty Products,Wayne,NJ,United States of America可獲得,60:40重量比之乙烯基吡咯啶酮:乙酸乙烯酯)、PVA之環氧乙烷接枝共聚物諸如KOLLICOATIR(自BASF可獲得,75重量%之聚乙烯醇(PVA),25重量%之聚乙二醇接枝)、聚乙烯醇(PVA)、丙烯酸酯及聚丙烯酸(包括聚丙烯酸酯聚合物、經交聯之聚丙烯酸酯聚合物、經交聯之聚丙烯酸(例如,CARBOPOL))、乙烯基己內醯胺/丙烯酸鈉聚合物、甲基丙烯酸酯、順丁烯二酸聚乙烯基烷基醚-順丁烯二酸共聚物(例如,GANTREZ)、乙酸乙烯酯與巴豆酸之共聚物、聚丙烯醯胺、聚(2-丙烯醯胺基-2-甲基丙烷磺酸酯)、丙烯基甲基丙基磺酸/甲基丙烯酸酯/苯乙烯單體之三元共聚物、膦酸酯苯乙烯聚合物、聚膦酸乙二酯、聚膦酸丁二酯、聚苯乙烯、聚乙烯基膦酸酯、聚伸烷基、聚伸烷基氧(包括聚伸乙基氧,即聚乙二醇)、及羧基乙烯基聚合物。如由熟諳之技術人員了解,薄膜亦可包含此等聚合物之衍生物、共聚物、及另外之混合物。
有用之不溶於水之聚合物包括可溶於至少一種有機溶劑中之聚合物;例如,丙烯酸系共聚物(其中尚未中和羧酸官能基)、經交聯之聚乙烯基吡咯啶酮(例如,自BASF可獲得之KOLLIDONCL或CL-M)、聚乙酸乙烯酯(PVAc)、某些纖維素衍生物(諸如纖維素乙酸酯、纖維素硝酸酯、烷基纖維素諸如乙基纖維素、丁基纖維素、及異丙基纖維素、纖維素乙酸酞酸酯)、蟲膠、乙烯-乙酸乙烯酯共聚物、乙酸乙烯酯同元聚合物、矽酮聚合物(例如,二甲基矽酮)、聚甲基丙烯酸甲酯(PMMA)、不溶於有機溶劑中之聚合物(諸如纖維素、聚乙烯、聚丙烯、聚酯、聚胺甲酸乙酯及耐隆)、天然及合成之橡膠、及其混合物。適合之形成薄膜之丙烯酸系共聚物之一種實例係LUVIMER30E,自BASF(Florham Park,NJ,United States of America)市售之丙烯酸第三丁酯/丙烯酸乙酯/甲基丙烯酸共聚物之於乙醇中之30重量%溶液。不溶於水之聚合物可係如分散液製備(例如,經由乳液聚合作用)及可係以適合之乳化劑安定化。例如,一種有用之PVAc乳液係KOLLICOATSR 30D,PVAc於水中以2.7重量百分比之PVP及0.3%之月桂硫酸鈉安定化之30重量%分散液。丙烯酸系共聚物分散液之一種實例係KOLLICOATEMM 30D,具有約800,000之報導之平均分子量之丙烯酸乙酯:甲基丙烯酸甲酯共聚物(丙烯酸乙酯對於甲基丙烯酸甲酯之重量比係約2比1)之30重量%水性分散液,自BASF可獲得。
其他有用之聚合物或水溶性填充劑包括,但不限於,天然膠諸如海藻酸鈉、鹿角菜苷、黃原膠、金合歡膠、阿拉伯膠、瓜爾豆膠、黏稠性多糖、洋菜、穀糖、聚葡萄胺糖、果膠、梧桐膠、玉米蛋白、大麥醇溶蛋白、麥醇溶蛋白、刺槐豆膠、黃耆及其他多醣;澱粉諸如麥芽糊精、直鏈澱粉、高直鏈澱粉含量之澱粉、玉米澱粉、馬鈴薯澱粉、稻米澱粉、木薯澱粉、豌豆澱粉、甘薯澱粉、大麥澱粉、小麥澱粉、蠟質種玉米澱粉、變性之澱粉(例如,經羥丙基化之高直鏈澱粉含量之澱粉)、糊精、聚果糖、elsinan及麩質;及蛋白質諸如膠蛋白、分離乳清蛋白、酪蛋白、牛乳蛋白、黃豆蛋白、角蛋白、及明膠。薄膜可另外包含可分散或可潤脹之填充劑諸如變性之澱粉、海藻酸酯、海藻酸之二價或多價之離子鹽。
不溶於水之聚合物之另外非限制之實例包括纖維素乙酸酯、纖維素硝酸酯、乙烯-乙酸乙烯酯共聚物、乙酸乙烯酯同元聚合物、乙基纖維素、丁基纖維素、異丙基纖維素、蟲膠、疏水之矽酮聚合物(例如,二甲基矽酮)、PMMA(聚甲基丙烯酸甲酯)、纖維素乙酸酞酸酯及天然或合成之橡膠;不溶於有機溶劑中之聚合物,諸如纖維素、聚乙烯、聚丙烯、聚酯、聚胺甲酸乙酯及耐隆。
於水性組成物中,於薄膜中之水溶性聚合物與不溶於水之聚合物及/或部分地水溶性聚合物之相對數量較佳地係致使該薄膜於水性組成物中係儲存安定的,但是於組成物之使用之期間分裂。於多種具體實施例中,薄膜包含以薄膜之重量計約0.1%至約90%、約1%至約80%、約5%至約70%、約9%至約50%或約10%至約40%之數量之水溶性聚合物。除了水溶性聚合物以外,或替代水溶性之聚合物,薄膜可包含以薄膜之重量計約0.1%至約50%,較佳地約1%至約10%之數量部分地不溶於水或可於水中潤脹之聚合物。於多種具體實施例中,於水性載體環境中安定化親水性薄膜之方法權衡於當儲存於產品載體中之安定性,但於一經使用後分裂以釋出於其中包含之活性成分,於薄膜中使用水溶性及不溶於水之材料。
較佳地,本發明之薄膜視需要包含一種或多種下列另外之成分:表面活性劑、黏度調節劑、增稠劑、保濕劑、稀釋劑、填充劑(除了以上敘述者以外)、pH調節劑、塑化劑、填充劑、蠟、質地調節劑、油、調味及/或甜味劑、防腐劑、溶劑、及其混合物。當然,雖然每種之以上種類之物質之一般性質可不同,但是可具有某些共同之性質,及任何指定之物質可適合於兩種或更多種種類之物質之範圍內之多種目的。
於薄膜中之一種或多種表面活性劑可充當界面活性劑、乳化劑、及/或泡沫調節劑作用。於多種之口部照護調配物中習用地使用表面活性劑,或界面活性劑,以提供存在之其他成分(尤其調味油)之溶解、分散、乳化及潤濕。於多種具體實施例中,表面活性劑經由完全地分散活性成分遍及薄膜中,及於某些情況中,當薄膜溶解時經由環繞之環境而達成增加之預防疾病之作用。此外,於多種具體實施例中,表面活性成分可改良薄膜組成物之化妝之外觀。適合之表面活性及乳化劑較佳地係於遍及寬廣之pH範圍內合理地安定者,包括非肥皂之陰離子、非離子、兩性離子及兩性之有機合成清潔劑。於某些具體實施例中,一種或多種界面活性劑係以薄膜之重量計約0.001%至約5%,更佳地約0.5%至約5%,及最佳地約1%至約3%之範圍內存在於薄膜組成物中。
於本發明之組成物中有用之非離子界面活性劑包括經由環氧烷(尤其環氧乙烷)與有機疏水化合物(其本質上可係脂族的或烷基芳族的)之縮合作用而製造之化合物。界面活性劑之一種族群係如“ethoxamers”-環氧乙烷與脂肪酸、脂肪醇、脂肪醯胺、多元醇(例如花楸丹單硬脂酸酯)及其類似物之縮合作用產物,而已為吾人所知。“Polysorbates”敘述經由乙氧基化花楸丹-脂肪酸酯之自由態羥基而製備之非離子界面活性劑之族群。彼等係,例如,如ICI America,Inc.(Bridgewater,New Jersy,United States of America)之TWEEN界面活性劑市售的。非限制之實例包括Polysorbate 20(聚氧乙烯20單月桂酸花楸丹酯,TWEEN20)及Polysorbate 80(聚氧乙烯20單油酸花楸丹酯,TWEEN80)。較佳之polysorbate包括每莫耳之花楸丹酯具有約20至60莫耳之環氧乙烷者。
其他適合之非離子界面活性劑包括聚(氧乙烯)-聚(氧丙烯)嵌段共聚物,特別地具有兩個聚(氧乙烯)嵌段及一個聚(氧丙烯)嵌段之此種類型之三嵌段聚合物。此等共聚物係以poloxamer之非獨占之名稱而商業上已為吾人所知的,該名稱係連同用以表示每種共聚物之個別認明之數字字尾使用。Poloxamer可具有變動含量之環氧乙烷及環氧丙烷,導致寬廣範圍之化學結構及分子量。一種較佳之poloxamer係Poloxamer 407,其係廣泛地可獲得,例如於BASF公司(Florham,Park,NJ,United States of America)之商品名稱PluronicF127下可獲得。
適合之非離子界面活性劑之其他非限制之實例包括自環氧乙烷與一種物質(該物質係環氧丙烷與伸乙二胺、長鏈第三級胺氧化物、長鏈第三級膦氧化物、長鏈二烷基亞碸及其類似物之反應產物)之縮合作用衍生之產物。
於本發明之具體實施例中,兩性離子之合成界面活性劑亦可係有用的。此等之某些可係寬廣地敘述如脂族四級銨、鏻、及鋶化合物之衍生物,其中脂族自由基可係直鏈或分枝的,及其中脂族取代基之一個包含8至18個碳原子、及一個包含陰離子水溶解化之基,例如,羧基、磺酸基、硫酸基、磷酸基或膦酸基。適合之兩性離子界面活性劑之一種實例係4-(N,N-二(2-羥基乙基)-N-十八基銨基)-丁烷-1-甲酸鹽。
其他適合之兩性離子界面活性劑包括甜菜鹼界面活性劑,諸如於頒予Polefka等人之美國專利第5,180,577號中揭示者。典型之烷基二甲基甜菜鹼包括癸基甜菜鹼2-(N-癸基-N,N-二甲基銨基)乙酸鹽、椰子基甜菜鹼、肉豆蔻基甜菜鹼、軟脂基甜菜鹼、月桂基甜菜鹼、鯨蠟基甜菜鹼、硬脂基甜菜鹼、及其類似物。醯胺基甜菜鹼係以椰子醯胺基乙基甜菜鹼、椰子醯胺基丙基甜菜鹼、月桂醯胺基丙基甜菜鹼及其類似物例示。特殊有用之甜菜鹼界面活性劑包括椰子醯胺基丙基甜菜鹼及月桂醯胺基丙基甜菜鹼。
適合之陰離子界面活性劑之實例係高碳脂肪酸單甘油酯單硫酸鹽之水溶性鹽(諸如經氫化之椰子油脂肪酸之經單硫酸化之單甘油酯之鈉鹽)、高碳烷基硫酸鹽諸如月桂硫酸鈉(SLS)、烷基芳基磺酸鹽諸如十二基苯磺酸鈉、高碳烷基磺酸基乙酸鹽、1,2-二羥基丙烷磺酸之高碳脂肪酸酯、及低碳脂族胺基羧酸化合物之實質上飽和之高碳脂族醯基醯胺(諸如於脂肪酸、烷基或醯基自由基中具有12至16個碳者)、及其類似物。最後提及之醯胺之實例係N-月桂醯基肌胺酸,及N-月桂醯基、N-肉豆蔻醯基、N-軟脂醯基肌胺酸之鈉、鉀、及乙醇胺鹽,其等較佳地實質上不含肥皂或相似之高碳脂肪酸物質。
薄膜視需要包含一種或多種塑化劑,其等容許薄膜之強度及撓性之調節。通常,塑化劑降低薄膜之挺度。塑化劑化合物可包括二醇諸如丙二醇或低分子量聚合物,例如,聚乙二醇諸如自Dow Chemical可獲得之約200至約600之分子量之任何CARBOwAXESTM
。亦可使用多元醇諸如甘油或丙二醇、山梨醇、木糖醇、甘油酯諸如三乙酸甘油酯(三醋精)、檸檬酸三乙酯及天然油諸如礦油、萞麻油及植物油。此等塑化劑視需要構成約1%至約50%、約5%至約30%、或約10%至約25%,以薄膜之重量計。
增積劑、填充劑成分、或黏度調節劑可改變薄膜之性質及亦可包含於其中。此等增積劑可包括可於粒子之形式之不溶於水中之無機材料諸如,例如,二氧化矽(矽石)、磷酸三鈣、磷酸二鈣(磷酸一氫鈣)、碳酸鈣、真珠母、及黏土。不溶於水中之有機增積劑可包括纖維素、聚乙烯、聚丙烯及來自馬鈴薯、玉米、燕麥、稻米、小麥或木薯之各種澱粉及變性之食物澱粉諸如,例如,麥芽糊精。增積劑係視需要以薄膜之重量計約1%至約50%、約5%至約30%、或約10%至約25%之數量存在。
適合之另外成分之非限制之實例包括黏土、包含疏水性有機非聚合之材料之混合物諸如蠟(例如,蜂蠟或石蠟)、質地調節劑(諸如於冷水中可潤脹、物理地改變及預膠化之澱粉)、及著色劑。於某些具體實施例中,薄膜包含石墨。
於多種具體實施例中,薄膜包含調配物著色劑,其對於薄膜、組成物、或兩種賦與顏色。於某些具體實施例中,薄膜碎體與載體對照,及係白色、黑色、或屬於相對於或對照於載體背景可見之任何顏色。有用之調配物著色劑包括非毒性之水溶性染料或顏料,諸如,例如,金屬氧化物〝沈澱色料〞。於某些具體實施例中,著色劑係經由管制之機關核准用於組合入食物或藥品中者,諸如由FDA核准使用於美國中之FD&C或D&C顏料及染料。有用之著色劑包括於各種比率之FD&C紅3號(四碘螢光黃之鈉鹽)、食品紅17號、6-羥基-5-{(2-甲氧基-5-甲基-4-磺酸基苯基)偶氮基}-2-萘磺酸之二鈉鹽、食品黃13號、喹啉黃或2-(2-喹啉基)二氫茚二酮之單及二磺酸之混合物之鈉鹽、FD&C黃5號(4-對磺酸基苯基偶氮基-1-對磺酸基苯基-5-羥基-吡唑-3-甲酸之鈉鹽)、FD&C黃6號(對磺酸基苯基偶氮基-B-萘酚-6-單磺酸之鈉鹽)、FD&C綠3號(4-{[4-(N-乙基-對磺酸基苄基胺基)-苯基]-(4-羥基-2-鋶基-苯基)-亞甲基}-[1-(N-乙基-N-對磺酸基苄基)-A-3,5-環己二烯亞胺]之二鈉鹽)、FD&C藍1號(二苄基二乙基二胺基三苯基卡必醇三磺酸anhydrite之二鈉鹽)、FD&C藍2號(靛藍之二磺酸之鈉鹽)、及其混合物。於一種具體實施例中,著色劑包含不溶於水之無機顏料,諸如二氧化鈦、氧化鉻綠、酞青素綠、群青藍、氧化鐵、或不溶於水之染料沈澱色料。於某些具體實施例中,染料沈澱色料包括FD&C染料之鈣或鋁鹽諸如FD&C綠1號沈澱色料、FD&C藍2號沈澱色料、D&C紅30號沈澱色料或FD&C黃15號沈澱色料。於某些具體實施例中,水溶性染料,諸如,例如,FD&C藍1號,係包含於不溶於水之聚合物(諸如,例如聚乙烯)之內,致使於聚乙烯粒狀物(例如,Microblue Spectrabeads,由Micropowders,Inc.銷售)中找到者。於某些具體實施例中,薄膜包含染料諸如D&C紅30號。於某些具體實施例中,使用白色著色劑,例如二氧化鈦(TiO2
)、以二氧化鈦塗布之雲母(例如,Timiron)、雲母、礦物、或黏土。於某些具體實施例中,著色劑係不自薄膜滲出之染料。於多種具體實施例中,薄膜包含以薄膜之重量計約0.5%至約20%、或薄膜之重量計約1%至約15%、或以薄膜之重量計約3%至約12%之含量的著色劑。
於本發明之某些具體實施例中,使用於口部照護組成物中之薄膜包含一種或多種調味劑,其可包括任何之已為熟諳之技術人員所知者,諸如天然及人造之調味料。此等調味劑可係合成之調味油及調味之香料、及/或油、樹脂油及衍生自植物、葉、花、果實及其類似物之萃取物、及其混合物。於某些具體實施例中,調味劑包含香精油、萃取物或調味之醛、酮、酯或醇,其賦與由綠薄荷(spearmint)、薄荷(peppermint)、鹿蹄草、黃樟、丁香、鼠尾草、油加利、馬鬱蘭、肉桂、檸檬、萊姆、葡萄柚、柑、蘋果、梨、桃、草莓、櫻桃、杏、西瓜、香蕉、咖啡、可可、薄荷腦、藏茴香酮、茴香腦及其混合物組成之群中選出之味道。代表性之調味油包括:綠薄荷油、肉桂油、薄荷油、丁香油、月桂油、百里香油、香柏葉油、荳蔻之油、鼠尾草之油、及苦杏仁之油。亦有用者係人造、天然或合成之香料諸如香草、巧克力、可樂、咖啡、可可及柑橘屬植物油(包括檸檬、橙、葡萄、萊姆及葡萄柚)及水果香精(包括蘋果、梨、桃、草莓、覆盆子、櫻桃、李、鳳梨、杏及其類似物,個別或組合方式)。於多種具體實施例中,香料係以薄膜之重量計約0.01%至約10%之數量組合於薄膜中。
於某些具體實施例中,組成物係口部照護組成物,其中使用甜味物質作為調味劑之替代或補充。適合之甜味劑係水溶性的及包括於薄膜之約0.01至約1%之濃度之糖精鈉、環己基氨基磺酸鈉、木糖醇、紫蘇糖、D-色胺酸、阿司巴丹、蔗糖素、二氫查耳酮及其類似物。最佳地,甜味物質係糖精鈉。
於本發明之某些具體實施例中,薄膜係多孔的。如於本文中使用,“多孔”意表具有複數之分散遍及主體之細孔。較佳地,於某些具體實施例中之細孔係開孔的,其中分散遍及薄膜之主體之細孔互相開啟以形成通過薄膜之主體之連續之路線或溝槽,因此容許溶劑及/或活性成分之進入及外出。細孔可係大細孔的(例如,大於約50奈米之平均細孔尺寸)、中細孔(例如,具有約2至約50奈米之平均細孔尺寸)或微細孔的(例如,於低於約2奈米或20埃之平均細孔尺寸)。
如上述,本發明之較佳具體實施例提供經由轉移於包含活性成分之介質中存在之至少一部分之活性成分而將活性成分引進入薄膜中。如先前討論,薄膜最初實質上不含受轉移之活性成分。可製備薄膜,致使其具有多種活性成分,及僅選擇之活性成分係經由介質而轉移至薄膜。於介質與薄膜之間存在活性成分之濃度梯度。雖然亦涵蓋其他相,諸如氣相或固相,但是較佳地,介質係液相或半固相。轉移至少一部分之存在於介質中之活性成分至薄膜。此可經由被動之質量輸送而發生,諸如活性成分通過濃度梯度之擴散以於周圍情況轉移活性成分進入薄膜中。或者,該轉移可包含施加於系統之某種形式之外部能量,例如為了促進熱力學之平衡、為了加速活性成分之轉移之速率、為了克服能量或質量轉移障壁、及其類似物。外部原動力之主動施加包括,例如,電力、熱、及壓力之施加。
於較佳具體實施例中,於轉移方法之期間,薄膜接觸介質。較佳地,薄膜係部分或完全沈浸於介質之內,以將曝露之表面積增加至最大,以協助與介質之最大數量之接觸,及因此活性化合物之最大數量之轉移。涵蓋任何形式之接觸;例如,可視需要將介質塗布於薄膜上或將薄膜沈浸於介質之內。視需要,可連續地或間斷地混合包含薄膜之介質。可以批式或連續方法進行轉移方法。
於較佳具體實施例中,介質係液相或半固相(例如,凝膠、糊劑)。介質包含活性成分,及較佳地具有至少一種其中分散活性成分之相。於介質中,活性成分可係懸浮及/或溶劑化於該至少一種相中。於介質中,活性成分可係包含於不連續相中。如由熟諳此項技藝者了解,介質可包含複數種相,諸如乳液或其他多相系統。例如,於活性成分係親脂之情況中,其可係分散於親脂相之內。同樣地,親水之活性成分較佳地係分散於相容之親水相中。介質可包含一種或多種溶劑(極性或非極性的)或用於懸浮之媒液(水性或非水性的)。
於某些具體實施例中,如將於以下較詳細地敘述,用於口部照護組成物、個人照護組成物、去污劑、及/或家庭照護組成物之載體包含介質,該介質包含活性成分,隨後至少一部分之活性成分之轉移。於此等具體實施例中,視特定之組成物而定,選擇介質以包含與計畫之用途相容之成分,其可包含載體成分之選擇。於某些具體實施例中,介質包含某種數量之極性溶劑,諸如5%至95重量%之水。其他非限制之成分包括另外之溶劑、多元醇、保濕劑、增稠劑、表面活性劑、及已為熟諳此項技藝者熟知之其他成分。於某些具體實施例中,介質包含多元醇,諸如甘油,其可與其他溶劑諸如水組合。
於多種具體實施例中,活性成分係以大於約0.01%,視需要大於約1%,視需要大於約5%,視需要大於約10%,視需要大於約20%,視需要大於約30%,視需要大於約50%及視需要大於約75%之濃度轉移。
較佳地,轉移至少一部分之來自介質之活性成分至薄膜。如由熟諳此項技藝者了解,轉移之期間可視於介質中存在之活性成分之數量、活性成分於薄膜中之合適之濃度及製造方法而變動。於某些具體實施例中,使用介質作為用於終端組成物或產品之載體。因此,組成物之載體視需要包含介質。此外,於某些具體實施例中,介質形成組成物之載體。載體可另外包含一種或多種另外之活性成分,其與受轉移進入薄膜中者無關。於其他具體實施例中,介質係用於轉移活性成分至薄膜之轉移介質,但該介質不是隨後使用於生成之組成物/產品中。
如由熟諳此項技藝者了解,介質之濃度係視主要用途而定。例如,於介質將組合入載體中之情況中,最適化活性成分之濃度,致使其於有效並且無毒性之良好濃度之範圍內,因此接近活性成分之有效數量。此外,於此種情況中,於組成物之儲存之期間,介質將接觸載體,致使轉移之期間係相對地長,因此使濃度梯度能接近於平衡(或容許活性成分由薄膜之不可逆之吸收)。於載體中,介質之稀釋之數量將進一步決定活性成分於介質中之需要之濃度(進一步解釋活性成分於薄膜中之合適之濃度)。於其他具體實施例中,例如,其中介質完全係轉移介質者,活性成分濃度可係相對地高,以協助較大之濃度梯度及活性成分之較快速轉移至薄膜。
於某些具體實施例中,轉移於周圍條件發生。於某些具體實施例中,轉移於高於或相等於約25℃發生。此外,於某些具體實施例中,轉移存在歷時低於約10小時,視需要低於約5小時,視需要低於約3小時,視需要低於約1小時,及視需要低於約30分鐘。於某些具體實施例中,轉移存在歷時低於約20分鐘,視需要低於約15分鐘,及視需要低於約10分鐘。於其他具體實施例中,轉移存在歷時約10至72小時或較長。於一種具體實施例中,轉移存在歷時低於約48小時,例如,歷時約24小時。於一種具體實施例中,介質包含於水溶液中之過氧化氫活性成分,其中過氧化氫之濃度係約1%至約50%重量比,約1%至約10%,視需要約1%至約5%重量比。最初,薄膜不包含過氧化物潔白劑。於24小時之後,薄膜包含以薄膜之重量計約0.01%至約10%,視需要約1%至約5%之過氧化氫。
因此,於某些具體實施例中,於轉移之後,於薄膜中存在之經轉移之活性成分之部分大於約0.01%係較佳的。於其他具體實施例中,於薄膜中存在之經轉移之活性成分之數量係大於約1%,視需要大於約5%,視需要大於約10%,視需要大於約20%,視需要大於約30%,視需要大於約40%,視需要大於約50%,視需要大於約60%,視需要大於約75%。然而,如由熟諳此項技藝者了解,活性成分於薄膜中之濃度可係很低的,例如,於使用香料、甜味劑、著色劑或有效藥物活性成分之情況中。此外,活性成分於薄膜中之濃度係視多種之因素而定,包括活性成分之有效數量、及薄膜接受及保留活性成分之傾向;其轉而可係視多種之因素而定,包括但不限於薄膜之多孔性、於薄膜與活性成分之間之化學相容性。
本發明之薄膜較佳地具有實質上層狀之結構。“層狀(lamellar)”結構於一個或兩個維(例如x或y維)中具有比於第三維(例如z維)中之結構之厚度實質上較大之尺寸,及通常包括,例如,實質上平面、分層、或鰓葉狀之形狀。於一種具體實施例中,層狀結構實質上係平面的,於x及y維中皆具有比z維者實質上較大之尺寸。於其他具體實施例中,層狀結構不是平面的。
以另一種方式表示,薄膜較佳地具有約5:1或較大之縱橫比。通常,縱橫比(AR)係定義如AR=L/D,其中L係最長之維之長度及D係最其最短之維之長度。於某些具體實施例中,薄膜碎體具有至少約10:1之縱橫比。於多種具體實施例中,薄膜碎體具有約5:1至約10,000:1之縱橫比。雖然於某些具體實施例中薄膜可係扭曲的,但是於一種具體實施例中,薄膜包含實質上連續之表面,其可表現出如實質上平坦之表面。於此等具體實施例中,薄膜可具有任何之多種形狀,包括具有平滑、彎曲之表面。此外,術語“薄膜”涵蓋單一之結構以及複數薄膜碎體。於某些具體實施例中,薄膜包含複數碎體,其等獨立地具有約0.1密耳至約10密耳之厚度,較佳地約0.5密耳至9密耳,及更佳地約1.2密耳至約3密耳。碎軆之較佳長度係至少約0.2毫米。
於多種具體實施例中,薄膜包含複數碎體或片。此等碎體可係屬於任何之多種形狀或形式,包括半固體或固體分別之部分、碎體、粒子、薄片、或其混合物。於多種具體實施例中,薄膜碎體具有可認知之形狀。於某些具體實施例中,薄膜碎體構成非隨機之形狀。此等形狀包括簡單之幾何形狀諸如多邊形、橢圓之形狀、三角形、四邊形(諸如正方形、長方形、菱形)、五邊形、六邊形、卵形、圓形、或數碼字、有生命或無生命物體之代表之形狀,諸如星、心、寶石、花、樹、酢漿草、字母、數字、動物、文字、及其類似物。
此外,複數之薄膜碎體可具有不同之組成,例如具有第一種複數之包含第一種顏色之薄膜碎體、及第二種複數之包含第二種顏色之薄膜碎體,其中第一種與第二種顏色係彼此相異的。涵蓋不同組成物之任何變換,例如,於組成物或不同之薄膜組成物中之任何數目之不同之活性成分。
於某些具體實施例中,可使用習用之擠製、吹氣模造、或溶劑澆鑄方法、或其他相似之方法而製備根據本發明之薄膜,所有方法皆已為熟諳之技術人員所熟知。例如,為了經由溶劑澆鑄而製備薄膜,將形成薄膜之聚合物可溶於或溶解於足夠數量之與該聚合物相容之溶劑中。適合之溶劑之實例包括水、醇、丙酮、醋酸乙酯或其混合物。
於某些具體實施例中,薄膜係溶液澆鑄。適合之溶劑之實例包括水、醇、丙酮、醋酸乙酯或其混合物。於一種具體實施例中,溶劑係較低分子量醇溶劑,諸如乙醇。雖然較寬廣範圍之厚度係可行的及由本發明所涵蓋,但是於將漿液澆鑄之後,乾燥薄層至約0.5密耳(13微米)至約2密耳(50微米)之較佳厚度。
於已形成溶液之後,可於攪拌下將塑化劑加入,及倘若必要可施加熱以協助溶解,直到已形成清澈並且均勻之溶液為止,接著藉由磨擦物、及任何另外成分之添加,諸如增積劑、塑化劑、表面活性劑、調味劑及/或甜味劑。可將溶液塗布於適合之載體底材材料上,及乾燥以形成薄膜。底材較佳地具有容許聚合物溶液均勻地散布遍及計劃之底材寬度而不浸透入以於兩片底材之間形成不能透過地強烈之結合之表面張力。適合之載體底材材料之實例包括玻璃、不鏽鋼、如TEFLON(DuPont,Wilmington,DE)市售之聚四氟乙烯(PTFE)、以聚乙烯浸漬之牛皮紙或聚酯塑膠襯墊。
可使用不負面地影響薄膜之活性成分或味道之乾燥烘箱、乾燥隧道、真空乾燥機、或任何其他適合之乾燥設備而於中等至高溫度空氣浴中乾燥薄膜。於乾燥之期間,薄膜可經歷優先之拉伸或其他排列方法,諸如沿著薄膜之預先決定之軸定向之空氣吹製,以排列磨擦物粒子,以於薄膜之內具有合適之排列。乾燥之薄膜之成形為碎體或於最後形式之形狀可經由簡單之刀片切削、旋轉或衝壓機模。視需要,載體底材可具有於其中形成之模,及漿液將於模中乾燥成為由模界定之預先決定之形狀。於本發明之某些具體實施例中,可將易碎之活性成分組合入薄膜組成物中而不影響或避免薄膜製造之某些態樣,因此致使能較容易、較經濟、並且較堅固之薄膜製造。
可使用已為熟諳之技術人員所知之習用成分,以形成於以上列出之組成物之載體。載體之特定之組成較佳地係視組成物之計畫之用途而定。載體可係於液相、半固相、或固相中。當組成物係口部照護或個人照護組成物時,彼等較佳地係於口內或皮膚(即,化妝)可接受之載體或媒液中供應。口部照護組成物可係於潔齒劑(包括牙膏、齒凝膠、漱口水、牙粉、及預防疾病之糊劑)、糖食(包括口香糖、粒狀物及咀嚼物)、薄膜、塗抹產品、職業之磨光調配物或其中使用磨擦物之於此項技藝中已為吾人所知之任何其他形式。個人照護組成物包括:肥皂、沐浴膠、身體洗劑、去角質凝膠、乳液、止汗劑及除臭劑產品、指甲照護產品、及其類似物。家庭照護組成物包括粉末、糊劑、清潔劑、織物軟化劑、去污劑及其類似物。特定之載體成分之選擇係視合適之產品形式而定。
於某些具體實施例中,載體係水性的,於其案例中載體較佳地包含約5%至95%之水。於其他具體實施例中,載體實質上不是水性的。
如由熟諳此項技藝者認知,組成物之載體視需要包含其他材料,包括例如,表面活性劑(諸如界面活性劑、乳化劑、及泡沫調節劑)、黏度調節劑及增稠劑、保濕劑、稀釋劑、填充劑、pH調節劑、著色劑、防腐劑、溶劑、及其混合物。當然,雖然每種之以上種類之物質之一般性質可不同,但是可具有某些共同之性質,及任何指定之物質可適合於兩種或更多種之此等種類之物質之範圍內之多種目的。
適合之表面活性劑係遍及寬廣之pH範圍內合理地安定及於此項技藝中已為吾人所熟知者,包括陰離子、非離子或兩性之界面活性劑,包括以上於薄膜組成物之內容中敘述者,其等於此處係有用的。
於關於以潔齒劑之形式之口部照護組成物之具體實施例中,例示之載體實質上係半固體或固體。潔齒劑通常包含表面活性劑、保濕劑、黏度調節劑及/或增稠劑、磨擦物、溶劑(諸如水)、調味劑及甜味劑。如由熟諳此項技藝者認知,除了先前敘述之成分外,口部照護組成物視需要包含其他物質,包括例如,潤滑劑、潤濕劑、口感劑(mouth feel agents)及其類似物。於頒予Boyd等人之美國專利第6,669,929號、頒予Gebreselassie等人之第6,379,654號、及頒予Nabi等人之第4,894,220號中揭示用於口部照護組成物之適合之載體之實例。
於多種具體實施例中,口部照護組成物係於單一部分或單一相之內供應。於其他具體實施例中,組成物包含分隔地維持之第一部分及第二部分兩者。分隔地維持部分僅需要以致使實質上避免組成物之一種部分與組成物之另一種部分之交互作用之方式,維持該等部分。通常,使用雙成分口部照護組成物,其中具有於組成物中包含之一種或多種不相容之成分。例如,倘若載體包含兩種不相容之活性成分,則分隔地維持彼等係有利的。雖然包含活性成分之薄膜通常提供某種程度之分隔,但是可能具有活性成分自薄膜進入載體中之某種移動,反之亦然,及因此,於某些情況中提供完全分隔之相可係良好的。成分之分隔可係經由於此項技藝中已為吾人所知或發現之任何方法而達成,及包括此等成分之分隔之化學、物理、及機械方法之任何組合。例如,可組合第一及第二不相容之成分但某些成分係經由包裹或包膠一種或兩種成分於保護之薄膜、塗膜、膠囊、膠微粒、及其類似物中而分隔地維持。
於關於糖食之形式之口部照護組成物之具體實施例中,例示之載體實質上係固體或半固體。糖食載體於此項技藝中係已為吾人所知的,及較佳地包括咀嚼膠載體,其通常具有咀嚼膠基材、一種或多種塑化劑、甜味劑、及調味劑。於皆頒予Chow等人之美國專利第5,833,954號及第5,933,786號、及頒予Stier等人之第6,770,264號中可找到適合之糖食載體之實例。
於某些具體實施例中,口部照護組成物係於口內可消耗之薄膜,於包含於薄膜載體內分散之活性成分之經轉移部分之碎體之形式。薄膜組成物可係任何之先前敘述者;然而,於某些具體實施例中,薄膜碎體較佳地具有不同於薄膜載體之組成,致使薄膜碎體係物理地及/或化學地與薄膜載體分隔。較佳之薄膜載體包括可溶解之薄膜或具有可移動之墊片之薄膜,如已為熟諳此項技藝者所知。於頒予Schiradi等人之美國專利第4,713,243號、皆頒予Xu等人之第6,419,903號、第6,419,906號、及第6,514,483號、及頒予Moro等人之美國專利公告第2004/0062724號中可找到適合之薄膜之非限制之實例。
可設計薄膜載體,以具有對應於以選擇之聚合物為基礎而預先決定之處理期間之溶解速率。較佳地,薄膜載體之溶解速率係致使該薄膜載體以比包含活性成分之薄膜較快之速率分裂或溶解,因此容許於載體薄膜中存在之活性成分(排除於薄膜中之經轉移之活性成分)、及包含經轉移之活性成分之薄膜之活性成分之受控制之釋出。載體薄膜可係由以上於包含經轉移之活性成分之薄膜之內容中敘述之相同形成薄膜之材料形成。
載體薄膜可係由任何習用之形成薄膜之方法製造,諸如先前敘述者。較佳地,於溶液澆鑄之後或於擠製之前,將包含活性成分之薄膜混合入薄膜中。載體薄膜厚度較佳地係比包含活性成分之薄膜碎體較厚。雖然較寬廣範圍之厚度係可行的,但是較佳之厚度係約0.5密耳至約20密耳。
於某些具體實施例中,組成物係於具有非水性載體之塗抹口內或指甲組成物之形式。塗抹載體係可流動黏性非水性之液體懸浮液,其係經由以柔軟之塗敷器之手動塗敷而塗敷至表面,諸如牙齒或指甲。於某些具體實施例中,塗抹口部照護組成物包含增進黏著之形成薄膜之聚合物劑,其係液體並且親水的,諸如聚伸烷基二醇聚合物,例如,環氧乙烷之非離子聚合物、或環氧乙烷與環氧丙烷之非離子嵌段共聚物(例如,Poloxamer共聚物)。塗抹載體亦視需要包含溶劑、塑化劑、增積劑、填充劑、或黏度調節劑。於頒予Santarpia等人之美國專利第6,770,266號、及頒予Hoic等人之第6,669,930號中討論適合之塗抹載體。
個人照護產品載體可係於寬廣種類之形式,諸如,例如乳液,其包括但不限於,水包油、油包水、水包油包水、及矽酮包水包油。乳液可涵蓋寬廣範圍之黏度,例如,約100厘泊至約200,000厘泊。其他適合之載體包括無水之液體溶劑諸如油(例如,植物油及礦油)、醇(例如,乙醇、異丙醇)及矽酮(例如,二甲矽酮烷、環甲矽酮烷(cyclomethicone));以水性為基礎之單相液體溶劑(例如,水-醇溶劑系統);及此等無水及以水性為基礎之單相液體溶劑之經增稠之形式(例如,其中溶劑之黏度係已經由適合之膠、樹脂、蠟、聚合物、鹽、及其類似物之添加而提高,以生成固體或半固軆)。如於以上討論,個人照護組成載體物時常包含潤滑劑、潤濕劑、或調節劑,其等亦可形成載體之溶劑之一部分。肥皂、凝膠、身體洗劑及其類似物較佳地包含表面活性劑清潔劑。於頒予Simon等人之美國專利第5,480,633號中討論此等載體之實例。
家庭照護或家務清潔組成物載體較佳地包含一種或多種表面活性清潔劑、清潔劑增滌劑諸如硫酸鹽(例如,硫酸鈉)、磷酸鹽(例如,磷酸三鈉、磷酸二鈉)、複合之磷酸鹽(例如,焦磷酸四鈉、三聚磷酸鈉、四磷酸鈉、六偏磷酸鈉)、矽酸鹽(例如,矽酸鈉、膠態矽酸鹽)、碳酸鹽(例如,碳酸鈉、碳酸氫鈉)、漂白之化合物(例如,次氯酸鈉、過硼酸鈉、過碳酸鈉)、以及選用之活化劑、pH緩衝劑、酶、調節劑、稀釋劑、及其類似物。於頒予Hokkirigawa等人之美國專利第6,670,318號、頒予Thomas等人之第5,294,364號、頒予Denis等人之第4,869,842號、頒予Lancz之第3,965,026號中敘述例示之去污劑。
本發明係經由下列之非限制之實例而進一步舉例說明。
使用於以下之表I中表列之成分,製備薄膜組成物。
薄膜係自水溶液澆鑄,其中固體之數量可自5%變動至60%。特定地,於表1中之實例1中,薄膜係自包含約70%水之漿液澆鑄。以9密耳將薄膜濕澆鑄於可移動之以聚乙烯塗布之紙腹板上,及於設定於80℃之烘箱中乾燥歷時約10分鐘。薄膜包含薄荷腦(為了呼吸清新及冷卻)。薄膜不含潔白劑。薄膜之成型為最後之形式係可經由簡單之刀片切削、旋轉或衝壓機模。
以相同於為了實例1所敘述者之方法,使用於以下之表Ⅱ中表列之成分製備薄膜組成物。薄膜包含薄荷腦,及不含潔白劑。
根據實例2,使用於以上之表Ⅱ中表列之成分製備薄膜組成物。自鑄製之薄膜切割小正方形(1/16吋寬)。以根據實例2之薄膜組成物,製備具有來自表Ⅲ之成分之雙相潔齒劑組成物。潔齒劑包含第一部分(部分A)及第二部分(部分B),及每部分係經由下列方法參考表Ⅲ而分別地製備。受轉移至薄膜之活性成分係潔白劑(過氧化氫)。將糖精鈉、氟化鈉、焦磷酸四鈉(TSPP)、葡萄糖酸鎂、及其他鹽分散於水中及於習用之混合機中於攪拌下混合。於攪拌下將保濕劑,例如,甘油及山梨醇,加入水混合物中。然後將有機之增稠劑(諸如鹿角菜苷、羧甲基纖維素、GANTREZ及任何聚合物)加入。將過氧化氫產物加入部分B中。攪拌生成之混合物,直到形成均勻之凝膠相為止。將混合物轉移至高速率真空混合機中,於該處將磨擦物及無機之增稠劑加入。於約20至50毫米表柱之真空下,於高速率混合混合物歷時5至30分鐘。將調味油稱重出,然後加入混合物中。最後,將界面活性劑,諸如月桂硫酸鈉(SLS)或聚乙二醇(PEG)進料入於分別之混合機中之個別之部分中。將來自實例2之薄膜片加入部分B調配物中及混合。生成之部分係均勻、半固體、可擠製之糊劑或凝膠產物。
部分A及部分B可係於具有隔片之雙相容器中供應,諸如具有聚乙烯障壁之雙室管容器。
於表Ⅳ中提供於自實例3之部分B移出之條片中之過氧化氫含量之測量,其係與比較實例A(一種市售之潔白條片,Crest WHITESTRIPS,來自Procter and Gamble Co.(Cincinnati,OH,United States of America))比較。此外,於色蔭中之改變之試驗顯示,於10至15次處理之過程中,實例3之潔白條片顯示與比較實例相似之使用SPECTROSHADETM
分析之stained unprophied molars之△E測量。於是,根據本發明之方法,活性成分之轉移提供具有有效數量之經轉移之活性成分之薄膜,致使薄膜係適合於口內潔白組成物中之使用。
除了製備僅一種單相及受轉移至薄膜之活性成分係抗細菌非離子經鹵化之二苯基醚(二氯苯氧氯酚)以外,以相同於為了實例3敘述之方法,使用以下於表V中之成分製備薄膜組成物。
可使用包含甘油及過氧化物作為活性成分之介質(例如,35%過氧化氫水溶液),以轉移活性成分至薄膜。可選擇多種之活性成分濃度。
使用根據實例2製備之薄膜組成物之碎體,使用作為以上實例3之部分B之一部分使用之甘油及過氧化物製備介質。薄膜係以0.5重量%提供及與甘油/過氧化物介質混合歷時1至5分鐘。然後將包含薄膜之介質組合返回入口部照護組成物之載體中,即,將其與部分B配方之其他成分混合,如以上敘述,然後於該處將其他成分加入。
使用於實例2中製備之薄膜組成物,根據表Ⅵ製備多種不同濃度之介質。轉移時間係對於實例A、B、及C之薄膜表示,將薄膜條片沈浸及混合入介質中。於各種轉移時間自介質移出之條片中測量之過氧化物含量係如於表Ⅵ中表示。造成之於薄膜中經轉移之過氧化物之數量顯示,以過氧化物於介質中之濃度、以及轉移時間之長度為基礎,可選擇轉移至薄膜之過氧化物之部分。當過氧化物於介質中之濃度係相對地高時,經轉移之過氧化物之數量同樣地係相對地高,及可減少所需要之轉移時間之長度以達成於薄膜中之相同濃度。
於多種具體實施例中,本發明提供轉移活性成分進入薄膜中之快速並且有效之方法。此外,經由預形成薄膜組成物及其後將活性成分引進至其中,該等方法特定言之係很適合於其中活性成分係脆的、或將係經由曝露於對於薄膜製造良好之條件而影響之具體實施例中。轉移進入薄膜中之活性成分於載體(該載體包含,例如,不相容之成分及界面活性劑)中之儲存後係安定的。此外,於製造工廠中,本發明之方法提供容易並且經濟之處理。
應瞭解,於本揭示中之說明及特定之實例係計畫僅用於舉例說明之目的及不是計畫以限制本揭示之範圍。
Claims (16)
- 一種製造薄膜之方法,包含:(a)將薄膜沈浸於包含活性成分之介質中約10至48小時,其中該活性成分係由下列組成之群中選出:牙齒潔白劑、抗微生物劑、防蛀劑、防牙垢劑、防齒斑劑、防黏著劑、脫過敏劑、消炎劑、唾液刺激劑;其中該薄膜係以從5%至60%之固體數量的水溶液澆鑄,再乾燥而具有13μm至50μm之厚度,且該薄膜包含以該薄膜之重量計0.1%至90%之水溶性聚合物、0.001%至5%之界面活性劑及1%至50%之塑化劑,且實質上不含該活性成分,其中該水溶性聚合物係選由羥烷基烷基纖維素、聚丙烯酸酯聚合物、經交聯之聚丙烯酸酯聚合物、經交聯之聚丙烯酸及順丁烯二酸聚乙烯基烷基醚-順丁烯二酸共聚物組成之群選出,且該塑化劑係選由丙二醇、聚乙二醇、甘油、山梨醇、木糖醇、三乙酸甘油酯及植物油組成之群選出;及(b)自該介質轉移至少一部分之該活性成分至該薄膜。
- 如請求項1之方法,其中該薄膜係多孔的。
- 如請求項1之方法,其中於該薄膜中之該經轉移之活性成分之數量係大於約0.5%,以該薄膜之重量計。
- 如請求項3之方法,其中於該薄膜中之該經轉移之活性成分之數量係約1%至約5%,以該薄膜之重量計。
- 如請求項1之方法,其中該轉移包含至少一種之該活性成 分自該介質之擴散至該薄膜、及該薄膜自該介質吸收該活性成分進入。
- 如請求項1之方法,其中該薄膜包含一種之表面活性劑、黏度調節劑、增稠劑、保濕劑、稀釋劑、填充劑、pH調節劑、塑化劑、填充劑、蠟、質地調節劑、調味及/或甜味劑、防腐劑、溶劑、及其混合物。
- 如請求項2之方法,其中於該轉移之後於該薄膜中之該活性成分之數量係大於約0.5%,以該薄膜之重量計。
- 如請求項7之方法,其中於該轉移之後於該薄膜中存在之該活性成分之數量係約1%至約5%,以該薄膜之重量計。
- 如請求項1之方法,其中該薄膜係沉浸於介質中約24小時。
- 一種製造口部照護組成物之方法,該方法包含:將薄膜沉浸於包含活性成分之介質中約10至48小時,其中該活性成分包含潔白劑;其中該薄膜係以從5%至60%之固體數量自水溶液澆鑄,再乾燥而具有13μm至50μm之厚度,且該薄膜包含以該薄膜之重量計0.1%至90%之水溶性聚合物、0.001%至5%之界面活性劑及1%至50%之塑化劑,且實質上不含該活性成分,其中該水溶性聚合物係選由羥烷基烷基纖維素、聚丙烯酸酯聚合物、經交聯之聚丙烯酸酯聚合物、經交聯之聚丙烯酸及順丁烯二酸聚乙烯基烷基醚-順丁烯二酸共聚物組成之群選出,且該塑化劑係選由丙二醇、聚乙二醇、甘油、山梨醇、木糖醇、三乙酸甘油酯及植物油組成之群選出; 自該介質轉移至少一部分之該活性成分至該薄膜;;及將包含該經轉移之活性成分之薄膜引進入一口內可接受的載體中。
- 如請求項10之方法,其中該潔白劑係由下列組成之群中選出之化合物:過氧化物、金屬氯酸鹽、聚乙烯基吡咯啶酮-過氧化氫複合物、過硼酸鹽、過碳酸鹽、過硫酸鹽、過磷酸鹽、過矽酸鹽、及過氧酸。
- 如請求項10之方法,其中所述的口部照護組成物係用於將其接觸口內表面。
- 如請求項10之方法,其中於該轉移之後於該薄膜中之該活性成分之數量係大於約0.5%,以該薄膜之重量計。
- 如請求項10之方法,其中於該轉移之後於該薄膜中存在之該活性成分之數量係約1%至約5%,以該薄膜之重量計。
- 如請求項10之方法,其中該薄膜係沉浸於介質中約24小時。
- 如請求項10之方法,其中該組成物係於由潔齒劑、糖食、及塗抹產品組成之群中選出之形式。
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/457,610 US9682256B2 (en) | 2006-07-14 | 2006-07-14 | Methods of making compositions comprising films |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200819149A TW200819149A (en) | 2008-05-01 |
| TWI429461B true TWI429461B (zh) | 2014-03-11 |
Family
ID=38895706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW096125482A TWI429461B (zh) | 2006-07-14 | 2007-07-13 | 製造薄膜及口部照護組成物之方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9682256B2 (zh) |
| EP (1) | EP2046264B1 (zh) |
| JP (1) | JP5361716B2 (zh) |
| CN (2) | CN104721062A (zh) |
| AR (1) | AR062076A1 (zh) |
| AU (1) | AU2007272773B2 (zh) |
| BR (1) | BRPI0714417B8 (zh) |
| CA (1) | CA2657323C (zh) |
| DK (1) | DK2046264T3 (zh) |
| ES (1) | ES2507555T3 (zh) |
| MX (1) | MX2009000451A (zh) |
| MY (1) | MY153658A (zh) |
| PL (1) | PL2046264T3 (zh) |
| RU (1) | RU2447879C2 (zh) |
| SG (1) | SG186650A1 (zh) |
| TW (1) | TWI429461B (zh) |
| WO (1) | WO2008008617A2 (zh) |
| ZA (1) | ZA200900241B (zh) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8336152B2 (en) * | 2007-04-02 | 2012-12-25 | C. R. Bard, Inc. | Insert for a microbial scrubbing device |
| US8065773B2 (en) | 2007-04-02 | 2011-11-29 | Bard Access Systems, Inc. | Microbial scrub brush |
| US9192449B2 (en) | 2007-04-02 | 2015-11-24 | C. R. Bard, Inc. | Medical component scrubbing device with detachable cap |
| US20090054533A1 (en) * | 2007-08-20 | 2009-02-26 | Suresh Rukmanand Pareek | Film coating compositions based on tribasic calcium phosphate |
| WO2009055048A1 (en) * | 2007-10-24 | 2009-04-30 | Bio Med Sciences, Inc. | Wrinkle reducing skin patch, process of manufacture and useful articles thereof |
| US10130597B2 (en) * | 2008-02-08 | 2018-11-20 | Colgate-Palmolive Company | Compositions and devices |
| EP2384740B1 (en) | 2008-02-08 | 2025-05-07 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
| US8696820B2 (en) | 2008-03-31 | 2014-04-15 | Bard Access Systems, Inc. | Method of removing a biofilm from a surface |
| DK2280686T3 (en) | 2008-04-11 | 2015-01-26 | Danisco Us Inc | Alpha-glucanase and oral care composition containing the same |
| US20090304608A1 (en) * | 2008-06-05 | 2009-12-10 | Innovasource, Llc | Aqueous Hydrogen Peroxide Solution for Use as a Disinfectant or Anti-Microbial Personal Care Product |
| TWI404544B (zh) | 2008-08-11 | 2013-08-11 | Colgate Palmolive Co | 含珠粒之口腔保健組成物 |
| US8069523B2 (en) | 2008-10-02 | 2011-12-06 | Bard Access Systems, Inc. | Site scrub brush |
| KR20120004495A (ko) | 2009-04-01 | 2012-01-12 | 씨. 알. 바드, 인크. | 미생물 세정 장치 |
| EP2414158B1 (en) | 2009-04-02 | 2015-11-04 | Colgate-Palmolive Company | Color changing consumer products |
| CA2753671C (en) * | 2009-04-02 | 2014-11-18 | Colgate-Palmolive Company | Dentifrice composition |
| TWI396554B (zh) * | 2009-05-26 | 2013-05-21 | Colgate Palmolive Co | 增進可溶性鋅的量之口腔保健調配物 |
| TWI442937B (zh) * | 2009-05-26 | 2014-07-01 | Colgate Palmolive Co | 較高含量的含鋅薄膜 |
| EP2504025A4 (en) * | 2009-11-23 | 2013-05-01 | Stephen F Olmstead | COMPOSITIONS AND METHODS USING SERRATIA PEPTIDASE FOR INHIBITING AND TREATING BIOFILMS ASSOCIATED WITH PARTICULAR SUFFERING |
| TWI458497B (zh) * | 2010-01-13 | 2014-11-01 | Colgate Palmolive Co | 口腔組成物中氧化鋅薄膜之安定化 |
| EP2528536B2 (en) * | 2010-01-29 | 2021-03-24 | Colgate-Palmolive Company | Dental strip for administration of oral treatment |
| GB2481630A (en) * | 2010-07-01 | 2012-01-04 | Robert Taylor | Composition for dental health |
| US20120087968A1 (en) * | 2010-10-07 | 2012-04-12 | Cryovac, Inc. | Antimicrobial Packaging Material and Methods of Making and Using the Same |
| WO2012078134A1 (en) | 2010-12-07 | 2012-06-14 | Colgate-Palmolive Company | Oral and personal care compositions comprising zinc containing films |
| WO2012082450A2 (en) * | 2010-12-13 | 2012-06-21 | Colgate-Palmolive Company | Oral compositions |
| SG190213A1 (en) * | 2010-12-13 | 2013-06-28 | Colgate Palmolive Co | Oral compositions and method for producing thereof |
| CA2819995A1 (en) * | 2010-12-13 | 2012-06-21 | Colgate-Palmolive Company | Oral flavored compositions comprising polymer matrix films and hydrophobic/lipophilic additives and alcohol-free method for producing thereof |
| SG190699A1 (en) * | 2010-12-13 | 2013-07-31 | Colgate Palmolive Co | Oral compositions and method for producing thereof |
| RU2593800C2 (ru) * | 2011-12-16 | 2016-08-10 | Колгейт-Палмолив Компани | Меняющие цвет композиции |
| EP2790647B1 (en) * | 2011-12-16 | 2016-06-29 | Colgate-Palmolive Company | Multiphase oral care compositions |
| CA2853654C (en) | 2011-12-16 | 2019-01-22 | Colgate-Palmolive Company | Film containing compositions |
| CN103987371B (zh) * | 2011-12-21 | 2017-04-26 | 高露洁-棕榄公司 | 口腔护理组合物 |
| US8999371B2 (en) * | 2012-03-19 | 2015-04-07 | Arges Imaging, Inc. | Contrast pattern application for three-dimensional imaging |
| WO2013148492A1 (en) * | 2012-03-29 | 2013-10-03 | Novozymes A/S | Use of enzymes for preparing water soluble films |
| US8962740B2 (en) | 2012-09-10 | 2015-02-24 | Kraft Foods Group Brands Llc | Oxygen scavenger system in a polyolefin matrix |
| JP6067342B2 (ja) * | 2012-11-16 | 2017-01-25 | 花王株式会社 | シート状化粧料 |
| PL2925818T3 (pl) * | 2012-11-30 | 2017-04-28 | Colgate-Palmolive Company | Kompozycje do pielęgnacji jamy ustnej o stabilnym kolorze |
| BR112015012347B1 (pt) | 2012-12-04 | 2019-01-02 | Colgate Palmolive Co | composição aquosa para limpeza, método compreendendo a aplicação da composição e uso do polietileno glicol em uma composição aquosa para limpeza |
| BR112015014006B1 (pt) | 2012-12-14 | 2019-03-19 | Colgate-Palmolive Company | Composições de cuidado oral estáveis ao peróxido |
| CA2891538C (en) * | 2012-12-18 | 2019-09-10 | Colgate-Palmolive Company | Oral care compositions with reduced astringency and improved phase stability comprising pyrophosphates, thickening gums, and metal ions |
| WO2014145699A1 (en) * | 2013-03-15 | 2014-09-18 | New Jersey Institute Of Technology | System and method for fabrication of uniform polymer films containing nano and micro particles via continuous drying process |
| WO2014198999A1 (en) * | 2013-06-13 | 2014-12-18 | Opes Corporation Oy | Matrix |
| EP3049158B1 (en) * | 2013-09-27 | 2019-10-23 | Rohm and Haas Company | Oral care composition |
| JP6315754B2 (ja) * | 2013-10-02 | 2018-04-25 | 花王株式会社 | シート状化粧料 |
| JP6228501B2 (ja) * | 2014-04-02 | 2017-11-08 | ツキオカフィルム製薬株式会社 | フィルム分散液、化粧品、医薬部外品、医療用皮膚外用剤、臓器癒着防止剤、及びガン治療剤 |
| DE202014101882U1 (de) * | 2014-04-22 | 2014-05-02 | Armin Armani | Orales Abgabesystem |
| PT3155050T (pt) * | 2014-06-06 | 2020-11-12 | Opes Corp Oy | Massa contendo composto funcional e regulador de viscosidade |
| JP6524117B2 (ja) * | 2014-06-30 | 2019-06-05 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 水溶性パウチ |
| AR103786A1 (es) * | 2014-10-13 | 2017-06-07 | Procter & Gamble | Artículos que comprenden una película soluble en agua de combinaciones de alcohol polivinílico y métodos relacionados |
| JP2015145377A (ja) * | 2015-03-02 | 2015-08-13 | コルゲート・パーモリブ・カンパニーColgate−Palmolive Company | 色を変化させる消費者用製品 |
| ES2913120T3 (es) | 2015-08-04 | 2022-05-31 | Isp Investments Llc | Polímeros derivados de éteres de alcohol vinílico aminofuncionales y aplicaciones de los mismos |
| RU2600795C1 (ru) * | 2015-11-19 | 2016-10-27 | Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт лекарственных и ароматических растений (ФГБНУ ВИЛАР) | Композиция растительного происхождения в виде мицеллярного раствора |
| US9808416B2 (en) * | 2015-12-09 | 2017-11-07 | Colgate-Palmolive Company | Oral care compositions and methods |
| US10153602B2 (en) * | 2015-12-16 | 2018-12-11 | Jeremy N. Wolfson | Electrical junction box system |
| AU2015418760B2 (en) * | 2015-12-29 | 2019-01-31 | Colgate-Palmolive Company | Cleansing composition |
| KR102562217B1 (ko) * | 2016-05-26 | 2023-07-31 | 주식회사 엘지생활건강 | 필름 조성물 |
| FR3052461B1 (fr) * | 2016-06-13 | 2020-01-10 | Coatex | Composition detergente polymerique sans phosphate |
| CN114869786B (zh) | 2016-08-11 | 2025-08-05 | 高露洁-棕榄公司 | 针对顽渍的过一硫酸盐牙粉组合物 |
| US20200040149A1 (en) * | 2016-10-06 | 2020-02-06 | Foundation For Research And Business, Seoul National University Of Science And Technology | Polymer-ceramic hybrid film having mechanical properties and elasticity, and method for manufacturing same |
| RU2730014C1 (ru) * | 2016-11-16 | 2020-08-14 | Колгейт-Палмолив Компани | Композиция для ухода за полостью рта |
| US10716742B2 (en) | 2016-11-16 | 2020-07-21 | Colgate-Palmolive Company | Oral care composition |
| US10543154B2 (en) | 2016-12-20 | 2020-01-28 | Colgate-Palmolive Company | Oral care composition |
| AU2017382568B2 (en) | 2016-12-20 | 2020-10-22 | Colgate-Palmolive Company | Oral care composition |
| CN110087610A (zh) | 2016-12-20 | 2019-08-02 | 高露洁-棕榄公司 | 口腔护理组合物 |
| DE102017103346A1 (de) | 2017-02-17 | 2018-08-23 | Lts Lohmann Therapie-Systeme Ag | Strukturierte orodispergierbare Filme |
| US10786448B2 (en) | 2018-01-18 | 2020-09-29 | Christian Arnold | Chewing gum composition comprising polyhexanide |
| CN108313367A (zh) * | 2018-02-27 | 2018-07-24 | 湖南尔康制药股份有限公司 | 一种充惰性气体包装的维c银翘片 |
| CN109549858B (zh) * | 2019-01-10 | 2020-07-07 | 乳源南岭好山好水化妆品有限公司 | 一种美白牙齿的凝胶及其制备方法 |
| GB2581142A (en) * | 2019-01-23 | 2020-08-12 | Linkage Tech Switzerland Sa | Compositions and their use |
| JP7654566B2 (ja) | 2019-05-14 | 2025-04-01 | コロプラスト アクティーゼルスカブ | グリセロールと、シクロデキストリンと、オクテニジンとを含有するエラストマーシリコーン組成物 |
| US20230120190A1 (en) * | 2020-01-29 | 2023-04-20 | Marcelo Rodrigues Teixeira | Oral composition with synergistic association of organic and inorganic components for full maintenance of oral health, process for obtaining and uses thereof |
| CN111436426B (zh) * | 2020-05-11 | 2022-04-08 | 北京首创股份有限公司 | 供水管道输水用二次加氯胶囊及其制备方法 |
| US20220047504A1 (en) * | 2020-05-27 | 2022-02-17 | Cure Pharmaceutical Holding Corp. | Oral dissolvable film with pores extending therethrough |
| US12151007B2 (en) | 2020-06-26 | 2024-11-26 | Colgate-Palmolive Company | Electrochemical tooth whitening composition and method thereof |
| US11826437B2 (en) | 2020-10-19 | 2023-11-28 | The Procter & Gamble Company | Oral care article comprising a hydrophobic delivery carrier and solid hydrophilic particle comprising a bleaching agent |
| AU2022224633B2 (en) | 2021-02-19 | 2024-10-24 | Colgate-Palmolive Company | Peroxymonosulfate whitening strips |
| CA3245536A1 (en) | 2022-04-07 | 2023-10-12 | Colgate-Palmolive Company | PERSONAL CARE COMPOSITIONS |
| CN116462978B (zh) * | 2023-04-23 | 2024-09-13 | 维斯克凡科技(苏州)有限公司 | 一种高弹性可食蛋白膜及其制备方法 |
| CN116473949A (zh) * | 2023-06-20 | 2023-07-25 | 山东利尔康医疗科技股份有限公司 | 一种含有抗菌肽的快速成膜的消毒液及其制备方法 |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3480557A (en) * | 1967-01-30 | 1969-11-25 | Gaf Corp | Solid stabilized hydrogen peroxide compositions |
| US3376110A (en) * | 1967-01-30 | 1968-04-02 | Gen Aniline & Film Corp | Solid stabilized hydrogen peroxide compositions |
| US3665026A (en) * | 1969-03-14 | 1972-05-23 | Gen Electric | Imidatosilanes |
| AU5697073A (en) | 1972-07-10 | 1974-12-19 | Colgate Palmolive Co | Liquid cleaner liquid cleaner |
| US3965027A (en) | 1974-03-11 | 1976-06-22 | Calgon Corporation | Scale inhibition and corrosion inhibition |
| US3950027A (en) * | 1974-10-15 | 1976-04-13 | Sybron Corporation | Armrest for dental chair |
| SU833999A1 (ru) | 1979-07-25 | 1981-05-30 | Московский Ордена Ленина И Орденатрудового Красного Знамени Государст-Венный Университет Им. M.B.Ломоносова | Способ получени гемосовместимыхпОлиМЕРНыХ МАТЕРиАлОВ |
| US4713243A (en) * | 1986-06-16 | 1987-12-15 | Johnson & Johnson Products, Inc. | Bioadhesive extruded film for intra-oral drug delivery and process |
| US4894220A (en) * | 1987-01-30 | 1990-01-16 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
| US5288480A (en) * | 1987-01-30 | 1994-02-22 | Colgate-Palmolive Co. | Antiplaque antibacterial oral composition |
| US5294364A (en) * | 1988-02-10 | 1994-03-15 | Colgate Palmolive | Safe acidic hard surface cleaner |
| US4869842A (en) * | 1988-03-31 | 1989-09-26 | Colgate-Palmolive Co. | Liquid abrasive cleansing composition containing grease-removal solvent |
| US4985238A (en) * | 1989-03-14 | 1991-01-15 | The Procter & Gamble Company | Low residue antiperspirant sticks |
| US5213716A (en) * | 1989-06-21 | 1993-05-25 | Colgate-Palmolive Company | Hair conditioning shampoo containing long chain alcohol component |
| US5180577A (en) * | 1990-10-09 | 1993-01-19 | Colgate-Palmolive | Stabilized bis biguanide/anionic active ingredient compositions |
| US5122370A (en) * | 1991-05-20 | 1992-06-16 | Isp Investments Inc. | Method for treating acne vulgaris with a composition containing a stable, high purity, substantially anhydrous complex of PVP-H2 O.sub.2 |
| CH682878A5 (fr) * | 1991-11-01 | 1993-12-15 | Nestle Sa | Procédé permettant d'éviter le brunissement d'un produit alimentaire. |
| US5681548A (en) * | 1994-07-15 | 1997-10-28 | Colgate Palmolive Company | Oral formulations |
| HUP9802268A3 (en) | 1995-09-18 | 2000-03-28 | Procter And Gamble Company Cin | Delivery systems for detergent comprising glass-stage granules |
| US5723500A (en) * | 1995-09-22 | 1998-03-03 | Colgate-Palmolive Company | Antiplaque oral composition and method |
| US5912274A (en) * | 1995-09-22 | 1999-06-15 | Colgate-Palmolive Company | Antiplaque oral composition and method |
| US5766574A (en) * | 1995-12-08 | 1998-06-16 | Colgate Palmolive Company | Dual component tooth whitening dentifrice |
| US5833954A (en) * | 1996-08-20 | 1998-11-10 | American Dental Association Health Foundation | Anti-carious chewing gums, candies, gels, toothpastes and dentifrices |
| US20030206874A1 (en) * | 1996-11-21 | 2003-11-06 | The Proctor & Gamble Company | Promoting whole body health |
| US6207186B1 (en) * | 1997-02-14 | 2001-03-27 | The Regents Of The University Of California | Lamellar gels and methods for making and using |
| US6280757B1 (en) * | 1997-05-22 | 2001-08-28 | The Procter & Gamble Company | Cleansing articles for skin or hair |
| US6287120B1 (en) * | 1998-12-04 | 2001-09-11 | Peter E. Wiesel | Methods and apparatus for treating teeth |
| RU11061U1 (ru) | 1999-04-30 | 1999-09-16 | Парамонов Борис Алексеевич | Перевязочное средство (варианты) |
| US6290933B1 (en) * | 2000-05-09 | 2001-09-18 | Colgate-Palmolive Company | High cleaning dentifrice |
| DE60143900D1 (de) | 2000-09-21 | 2011-03-03 | Align Technology Inc | System zur gleichzeitigen zahnrepositionierung und substanzverabreichung |
| US6685921B2 (en) * | 2000-10-25 | 2004-02-03 | The Procter & Gamble Company | Dental care compositions |
| US6379654B1 (en) * | 2000-10-27 | 2002-04-30 | Colgate Palmolive Company | Oral composition providing enhanced tooth stain removal |
| US20020131990A1 (en) * | 2000-11-30 | 2002-09-19 | Barkalow David G. | Pullulan free edible film compositions and methods of making the same |
| BR0017380A (pt) * | 2000-12-08 | 2004-01-06 | Kerrhawe Sa | Componente abrasivo para um agente de limpeza em um produto de limpeza próprio para uso em superfìcies delicadas, especialmente em dentes |
| JP2002193775A (ja) | 2000-12-21 | 2002-07-10 | Lion Corp | 歯の美白用セット |
| US6514483B2 (en) * | 2001-03-12 | 2003-02-04 | Colgate Palmolive Company | Strip for whitening tooth surfaces |
| US6419906B1 (en) * | 2001-03-12 | 2002-07-16 | Colgate Palmolive Company | Strip for whitening tooth surfaces |
| JP2002317197A (ja) * | 2001-04-19 | 2002-10-31 | Minebea Co Ltd | 液体クレンザー |
| US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
| US20030235549A1 (en) | 2001-05-01 | 2003-12-25 | Parminder Singh | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
| US6585997B2 (en) * | 2001-08-16 | 2003-07-01 | Access Pharmaceuticals, Inc. | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| US6419903B1 (en) * | 2001-08-20 | 2002-07-16 | Colgate Palmolive Company | Breath freshening film |
| US20030082131A1 (en) * | 2001-08-21 | 2003-05-01 | Colgate-Palmolive Company | Liquid cleaning compositions |
| US6770264B2 (en) * | 2001-11-13 | 2004-08-03 | Noville, Inc. | Chewing gum compositions comprising diglycerol |
| US7074426B2 (en) * | 2002-03-27 | 2006-07-11 | Frank Kochinke | Methods and drug delivery systems for the treatment of orofacial diseases |
| CA2703698C (en) * | 2002-04-30 | 2016-11-22 | Unigen Pharmaceuticals, Inc. | Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| US6770266B2 (en) * | 2002-05-24 | 2004-08-03 | Colgate Palmolive Company | Liquid tooth whitening composition |
| FR2840221B1 (fr) | 2002-06-04 | 2006-01-13 | Backert Marie Elisabeth Cuine | Film polymerique contenant des "actifs" destines a etre liberes dans un liquide |
| US6835373B2 (en) * | 2002-07-12 | 2004-12-28 | The Procter & Gamble Company | Non-irritating antiperspirant compositions containing acidic antiperspirant active |
| US7056494B2 (en) * | 2002-09-03 | 2006-06-06 | Kos Pharmaceuticals, Inc. | Method of treating a systemic disease |
| US20050019277A1 (en) | 2002-09-11 | 2005-01-27 | The Procter & Gamble Company | Tooth whitening products |
| US20040120903A1 (en) | 2002-09-11 | 2004-06-24 | The Procter & Gamble Company | Tooth whitening strips |
| US6835374B2 (en) * | 2002-10-23 | 2004-12-28 | Reheis, Inc. | Antiperspirant/deodorant active for no white residue sticks and soft solids |
| AU2003301110B2 (en) | 2002-12-30 | 2008-10-23 | Colgate-Palmolive Company | Oral care compositions and methods |
| US6669929B1 (en) * | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
| US6669930B1 (en) * | 2003-01-15 | 2003-12-30 | Colgate Palmolive Company | Liquid tooth whitening gel |
| GB2399351B (en) * | 2003-01-30 | 2005-12-07 | Nat Inst Of Advanced Ind Scien | Method for forming film |
| JP2007507491A (ja) | 2003-09-29 | 2007-03-29 | シージェー コーポレーション | 徐放性製剤 |
| CN1893911B (zh) * | 2003-11-17 | 2010-12-29 | 赛德玛公司 | 含有四肽和三肽混合物的配方 |
| SG151278A1 (en) | 2003-12-16 | 2009-04-30 | Colgate Palmolive Co | Oral and personal care compositions and methods |
| JP4596774B2 (ja) | 2003-12-26 | 2010-12-15 | 独立行政法人 日本原子力研究開発機構 | 化粧料 |
| GB0403808D0 (en) | 2004-02-20 | 2004-03-24 | Bioprogress Technology Ltd | Films for use as dosage forms |
| EP1737416A1 (en) | 2004-03-03 | 2007-01-03 | Warner-Lambert Company LLC | Film compositions |
| US20050196446A1 (en) * | 2004-03-05 | 2005-09-08 | Huang Hai Y. | Polymeric compositions and dosage forms comprising the same |
| US20050196448A1 (en) * | 2004-03-05 | 2005-09-08 | Hai Yong Huang | Polymeric compositions and dosage forms comprising the same |
| US20050196442A1 (en) * | 2004-03-05 | 2005-09-08 | Huang Hai Y. | Polymeric compositions and dosage forms comprising the same |
| US20050196447A1 (en) * | 2004-03-05 | 2005-09-08 | Huang Hai Y. | Polymeric compositions and dosage forms comprising the same |
| EP1602713B1 (en) * | 2004-06-04 | 2006-10-11 | The Procter & Gamble Company | Encapsulated particles |
| US8119169B2 (en) * | 2004-12-28 | 2012-02-21 | Colgate-Palmolive Company | Oregano oral care compositions and methods of use thereof |
| US20060140885A1 (en) * | 2004-12-29 | 2006-06-29 | Abdul Gaffar | Method of reducing oral tissue inflammation using magnolia extract |
-
2006
- 2006-07-14 US US11/457,610 patent/US9682256B2/en active Active
-
2007
- 2007-06-26 CA CA2657323A patent/CA2657323C/en not_active Expired - Fee Related
- 2007-06-26 AU AU2007272773A patent/AU2007272773B2/en not_active Ceased
- 2007-06-26 CN CN201510103610.9A patent/CN104721062A/zh active Pending
- 2007-06-26 EP EP07812314.8A patent/EP2046264B1/en not_active Revoked
- 2007-06-26 CN CNA2007800337329A patent/CN101511326A/zh active Pending
- 2007-06-26 JP JP2009519576A patent/JP5361716B2/ja not_active Expired - Fee Related
- 2007-06-26 ES ES07812314.8T patent/ES2507555T3/es active Active
- 2007-06-26 MY MYPI20090147A patent/MY153658A/en unknown
- 2007-06-26 RU RU2009105101/15A patent/RU2447879C2/ru not_active IP Right Cessation
- 2007-06-26 MX MX2009000451A patent/MX2009000451A/es active IP Right Grant
- 2007-06-26 WO PCT/US2007/072081 patent/WO2008008617A2/en not_active Ceased
- 2007-06-26 PL PL07812314T patent/PL2046264T3/pl unknown
- 2007-06-26 SG SG2012091617A patent/SG186650A1/en unknown
- 2007-06-26 DK DK07812314.8T patent/DK2046264T3/da active
- 2007-06-26 BR BRPI0714417A patent/BRPI0714417B8/pt not_active IP Right Cessation
- 2007-07-13 AR ARP070103148A patent/AR062076A1/es unknown
- 2007-07-13 TW TW096125482A patent/TWI429461B/zh not_active IP Right Cessation
-
2009
- 2009-01-12 ZA ZA2009/00241A patent/ZA200900241B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG186650A1 (en) | 2013-01-30 |
| CN104721062A (zh) | 2015-06-24 |
| ES2507555T3 (es) | 2014-10-15 |
| AU2007272773B2 (en) | 2011-03-31 |
| BRPI0714417B1 (pt) | 2015-11-24 |
| MX2009000451A (es) | 2009-01-27 |
| US20080014224A1 (en) | 2008-01-17 |
| JP2009543900A (ja) | 2009-12-10 |
| MY153658A (en) | 2015-03-13 |
| DK2046264T3 (da) | 2014-10-27 |
| TW200819149A (en) | 2008-05-01 |
| JP5361716B2 (ja) | 2013-12-04 |
| HK1128129A1 (zh) | 2009-10-16 |
| AR062076A1 (es) | 2008-10-15 |
| ZA200900241B (en) | 2014-10-29 |
| US9682256B2 (en) | 2017-06-20 |
| AU2007272773A1 (en) | 2008-01-17 |
| EP2046264A2 (en) | 2009-04-15 |
| BRPI0714417B8 (pt) | 2016-12-27 |
| RU2447879C2 (ru) | 2012-04-20 |
| CA2657323A1 (en) | 2008-01-17 |
| BRPI0714417A2 (pt) | 2013-04-02 |
| CA2657323C (en) | 2013-04-16 |
| EP2046264B1 (en) | 2014-08-06 |
| WO2008008617A3 (en) | 2008-03-20 |
| RU2009105101A (ru) | 2010-08-27 |
| PL2046264T3 (pl) | 2015-01-30 |
| WO2008008617A2 (en) | 2008-01-17 |
| CN101511326A (zh) | 2009-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI429461B (zh) | 製造薄膜及口部照護組成物之方法 | |
| TWI380827B (zh) | 具有交聯聚合物過氧化物之口護理組成物 | |
| EP1200064B1 (en) | Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip | |
| TW200810786A (en) | Oral compositions comprising siloxane polymers | |
| ES2543613T3 (es) | Películas y composiciones que comprenden las mismas | |
| US20070254067A1 (en) | Consumer customizable oral care products | |
| CN101132758A (zh) | 两相增白的口腔护理组合物 | |
| HK1128129B (zh) | 製造包含薄膜合成物的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |